Neurobiology of addiction: a neurocircuitry analysis
Open accessAbstract
Drug addiction represents a dramatic dysregulation of motivational circuits that is caused by a combination of exaggerated incentive salience and habit formation, reward deficits and stress surfeits, and compromised executive function in three stages. The rewarding effects of drugs of abuse, development of incentive salience, and development of drug-seeking habits in the binge/intoxication stage involve changes in dopamine and opioid peptides in the basal ganglia. The increases in negative emotional states and dysphoric and stress-like responses in the withdrawal/negative affect stage involve decreases in the function of the dopamine component of the reward system and recruitment of brain stress neurotransmitters, such as corticotropin-releasing factor and dynorphin, in the neurocircuitry of the extended amygdala. The craving and deficits in executive function in the so-called preoccupation/anticipation stage involve the dysregulation of key afferent projections from the prefrontal cortex and insula, including glutamate, to the basal ganglia and extended amygdala. Molecular genetic studies have identified transduction and transcription factors that act in neurocircuitry associated with the development and maintenance of addiction that might mediate initial vulnerability, maintenance, and relapse associated with addiction.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
83 of 172 cited sources checked · 34 supported · 2 flagged · accuracy not yet measured
- Premisecitation
Key synaptic changes involve glutamate-modulated NMDA and AMPA receptors in glutamatergic projections from the prefrontal cortex and amygdala to the VTA and nucleus accumbens.
“Key synaptic changes involve glutamate-modulated N-methyl-D-aspartate (NMDA) receptors and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in glutamatergic projections from the prefrontal cortex and amygdala to the ventral tegmental area and nucleus accumbens (table 2, circuit 4).”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [32] Kalivas, 2009, The glutamate homeostasis hypothesis of addiction, Nat Rev Neurosci source
- cites [43] Lüscher, 2011, Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling, Neuron source
The Molecular mechanisms sections for the VTA and nucleus accumbens (page numbers unavailable) describe drug-evoked changes involving AMPA and NMDA receptors and identify excitatory inputs from the prefrontal cortex and amygdala. But the VTA section explicitly says it remains unknown which specific inputs undergo drug-evoked plasticity, so the claim is too specific in placing those receptor changes in the named projections. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [46] Wolf, 2010, AMPA receptor plasticity in the nucleus accumbens after repeated exposure to cocaine, Neurosci Biobehav Rev source
Section 1.1 describes glutamate inputs from cortical and limbic regions to the nucleus accumbens and cocaine-related AMPA receptor plasticity there. Section 5.3 also reports NMDA receptor-dependent plasticity in VTA dopamine neurons. The paper does not establish the claimed receptor changes specifically in projections from both the prefrontal cortex and amygdala to both the VTA and nucleus accumbens. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
The ascending mesocorticostriatal dopamine system has a key role in the rewarding properties of nearly all drugs of abuse.
“A principal focus of research on the neurobiology of the rewarding effects of abused drugs has been the origins and terminal areas of the ascending mesocorticostriatal dopamine systems that have a key role in the rewarding properties of nearly all drugs of abuse (table 1).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [34] Wise, 2009, Roles for nigrostriatal—not just mesocorticolimbic—dopamine in reward and addiction, Trends Neurosci source
The Introduction and Summary and conclusions describe dopamine as important to reward and addiction, and Intravenous cocaine reward gives evidence for its role in cocaine reward. The paper also emphasizes that nigrostriatal dopamine matters, not just mesocorticolimbic dopamine. Our copy does not establish the claim’s scope of “nearly all drugs of abuse.” No page numbers were provided for these passages. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Interpretationcitation
Conditioned cues in the incentive salience process appear to drive dopamine signalling to maintain drug-taking motivation even when pharmacological effects diminish.
“Conditioned cues within the incentive salience process appear to drive dopamine signalling to maintain motivation to take the drug, even when its pharmacological effects lessen.”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [57] Schultz, 1997, A neural substrate of prediction and reward, Science source
In “Information Encoded in Dopaminergic Activity” (p. 2), the paper reports that a reward-predicting cue activates dopamine neurons after learning, while the predicted reward no longer produces a phasic response. It does not establish that this occurs through incentive salience, maintains motivation to take a drug, or persists as a drug’s pharmacological effects lessen; the reported cue experiment used a light predicting a reward in monkeys. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [60] Roitman, 2004, Dopamine operates as a subsecond modulator of food seeking, J Neurosci source
The Discussion (specific page not indexed) reports that learned sucrose-predictive cues evoke dopamine release and links dopamine rises to food-seeking responses. It also compares response initiation for sucrose and cocaine, but does not say that conditioned cues maintain drug-taking motivation as a drug’s pharmacological effects lessen. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [61] Volkow, 2014, Stimulant-induced dopamine increases are markedly blunted in active cocaine abusers, Mol Psychiatry source
- Premisecitation
Chronic administration of all major drugs with dependence or abuse potential dysregulates the hypothalamic-pituitary-adrenal axis and the CRF brain stress system, with elevated ACTH, corticosterone, and amygdala CRF during acute withdrawal.
“Both the hypothalamic-pituitary-adrenal axis and brain stress system mediated by CRF are dysregulated by the chronic administration of all major drugs with dependence or abuse potential, with a common response of elevated adrenocorticotropic hormone, corticosterone, and amygdala CRF during acute withdrawal.”
Quote in the paperSubstantial claim1 of 2 sources checked - Premisecitation
In humans, intoxicating doses of alcohol and drugs release dopamine and opioid peptides into the ventral striatum.
“In humans, positron emission tomography studies have shown that intoxicating doses of alcohol and drugs release dopamine and opioid peptides into the ventral striatum,”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [16] Mitchell, 2012, Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens, Sci Transl Med source
- cites [35] Volkow, 2007, Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement, J Neurosci source
The Abstract reports that PET-measured dopamine increased in the ventral striatum after methylphenidate in human subjects, supporting the drug-related dopamine portion. The study used methylphenidate as a challenge in detoxified alcoholics and controls; it does not report that intoxicating alcohol doses release dopamine or that alcohol or drugs release opioid peptides into the ventral striatum. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Drugs mimic the dopamine increases produced by phasic dopamine firing associated with rewarding stimuli.
“In this respect, drugs emulate the increases in dopamine triggered by phasic dopamine firing, which are the firing frequencies of dopamine neurons associated with rewarding stimuli.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [42] Covey, 2014, Illicit dopamine transients: reconciling actions of abused drugs, Trends Neurosci source
- Premisecitation
In animal models of the transition to addiction, brain reward threshold elevations temporally precede and are highly correlated with escalation in drug intake.
“In animal models of the transition to addiction, elevations in brain reward thresholds occur that temporally precede and are highly correlated with escalation in drug intake.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [20] Koob, 2014, Addiction as a stress surfeit disorder, Neuropharmacology source
- Premisecitation
Fast and steep dopamine release is associated with the subjective high.
“and that fast and steep release of dopamine is associated with the subjective sensation of the so-called high.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [36] Volkow, 2003, The addicted human brain: insights from imaging studies, J Clin Invest source
- Interpretationcitation
With chronic drug exposure, endocannabinoid neuroadaptations that modulate stress responses may contribute to enhanced stress reactivity in addiction.
“In particular, with chronic drug exposure, neuro-adaptations in the endocannabinoid system, which modulates the response of the brain to stress,85 might contribute to the enhanced stress reactivity in addiction.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [85] Gunduz-Cinar, 2013, Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity, Mol Psychiatry source
- Premisecitation
κ opioid receptor antagonists injected into the nucleus accumbens shell block the development of compulsive drug seeking.
“Equally compelling, κ opioid receptor antagonists, when injected into the nucleus accumbens shell, can block the development of compulsive drug seeking (tables 1, 2, circuit 8).”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [76] Walker, 2008, Pharmacological evidence for a motivational role of κ-opioid systems in ethanol dependence, Neuropsychopharmacology source
The Drugs section says the κ-opioid receptor antagonist nor-BNI was injected into the lateral ventricles, not the nucleus accumbens shell. The Nor-Binaltorphimine results report reduced ethanol self-administration in dependent rats during withdrawal, not prevention of the development of compulsive drug seeking. The claim captures an effect of κ-opioid antagonism on drug-related responding but changes both the injection site and the outcome. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites [77] Schlosburg, 2013, Long-term antagonism of κ opioid receptors prevents escalation of and increased motivation for heroin intake, J Neurosci source
Experiment 3 reports that injecting the κ opioid receptor antagonist nor-BNI into the nucleus accumbens shell prevented escalation of heroin intake and reduced motivation for heroin in long-access rats. The Abstract describes the measured responding as “compulsive-like.” The claim omits those limits and states more broadly that the injection blocks the development of compulsive drug seeking. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [78] Whitfield, 2015, κ opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake, J Neurosci source
The section on direct nor-BNI injection into the NAc shell (page not provided) reports that the antagonist prevented the emergence and/or expression of escalated methamphetamine intake in rats. It does not establish that injection specifically blocks the development of compulsive drug seeking across drugs: the authors leave development versus expression unresolved and describe the measured behavior as compulsive-like methamphetamine seeking and taking. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Interpretationcitation
Enduring aversive emotional states mediated by overactive stress and anti-reward systems or underactive anti-stress systems may contribute to chronic relapse long after acute withdrawal.
“Thus, the development of enduring aversive emotional states,88 mediated by overactivation of the stress and anti-reward systems or underactivation of the anti-stress systems, might contribute to the crucial problem in drug addiction of chronic relapse, in which individuals with addiction return to compulsive drug taking long after acute withdrawal.”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [2] Koob, 2008, Addiction and the brain antireward system, Annu Rev Psychol source
- cites [88] Leventhal, 2008, Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder, Am J Addict source
The Introduction reports that anhedonia may persist during extended stimulant remission and suggests that anhedonic people who have quit may be more prone to relapse. The paper does not attribute these symptoms or relapse risk to overactive stress or anti-reward systems or underactive anti-stress systems; its Discussion instead mentions dopamine-pathway dysregulation. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Stress-induced reinstatement of drug-related responding in animal models depends on activation of CRF and norepinephrine in the extended amygdala and the ventral tegmental area.
“By contrast, the stress-induced reinstatement of drug-related responding in animal models appears to depend on the activation of both CRF and norepinephrine in elements of the extended amygdala (ie, central nucleus of the amygdala and bed nucleus of the stria terminalis; tables 1, 2, circuits 16 and 17)22,33,53,96–98 and the ventral tegmental area (tables 1, 2, circuit 9).”
Quote in the paperSubstantial claim1 of 6 sources checked- cites [22] Delfs, 2000, Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion, Nature source
- cites [33] Shalev, 2002, Neurobiology of relapse to heroin and cocaine seeking: a review, Pharmacol Rev source
- cites [53] Shaham, 2003, The reinstatement model of drug relapse: history, methodology and major findings, Psychopharmacology (Berl) source
- cites [96] Shaham, 2000, Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons, Eur J Neurosci source
- cites [97] Shaham, 1998, CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats, Psychopharmacology (Berl) source
- cites [98] Merlo Pich, 1995, Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis, J Neurosci source
The Results report increased amygdala CRF-like immunoreactivity during restraint stress, and the Discussion proposes that norepinephrine may trigger CRF release in the central amygdala (page numbers unavailable). The paper does not establish that either system is required for stress-induced reinstatement of drug-related responding, nor does it establish the claimed roles of the bed nucleus of the stria terminalis or ventral tegmental area. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
As tolerance and withdrawal develop, CRF, norepinephrine, and dynorphin are recruited in the extended amygdala and contribute to negative emotional states in withdrawal and protracted abstinence.
“As tolerance and withdrawal develop, brain stress systems, such as CRF, norepinephrine, and dynorphin, are recruited in the extended amygdala and contribute to the development of negative emotional states in withdrawal and protracted abstinence (tables 1, 2, circuits 6–8).”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [20] Koob, 2014, Addiction as a stress surfeit disorder, Neuropharmacology source
The paper’s Abstract says that CRF and dynorphin are recruited in the extended amygdala as dependence and withdrawal develop, and hypothesizes that this produces negative emotional symptoms during acute and protracted abstinence. Its “Brain stress systems” passage lists norepinephrine as a stress-related neurotransmitter but does not say it is recruited in the extended amygdala during withdrawal. The claim also substitutes tolerance for the paper’s dependence and states its proposed mechanism more definitively. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [22] Delfs, 2000, Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion, Nature source
- Premisereasoning
The prefrontal cortex is positioned to regulate incentive salience and conditioned behaviour when a salient cue is presented.
“Thus, the prefrontal cortex is in a good position to regulate incentive salience and conditioned behaviour when a salient cue is presented to the individual.92,93”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [92] Jentsch, 1999, Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli, Psychopharmacology (Berl) source
- cites [93] Chudasama, 2006, Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans, Biol Psychol source
Section 6.2 (page unavailable) reports that orbitofrontal lesions impair rats’ approach to reward-predictive cues, supporting a prefrontal role in conditioned behaviour. Section 2.1 (page unavailable) describes prefrontal regulation of dopamine activity in the ventral striatum. The paper does not explicitly establish that the prefrontal cortex regulates incentive salience when a salient cue is presented, so that part of the attribution is not supported. (LLM, conf=0.79)
Experimental — accuracy not yet measured
- Premisecitation
The lateral habenula plays a key role in mediating and encoding aversive states.
“The lateral habenula plays a key role in mediating and encoding aversive states.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [79] Hikosaka, 2010, The habenula: from stress evasion to value-based decision-making, Nat Rev Neurosci source
- Premisecitation
In humans, cue-induced craving involves activation of circuits similar to those in animals, with drug-associated and non-drug addiction cues activating the prefrontal cortex, including dorsolateral prefrontal cortex, anterior cingulate gyrus, and medial orbitofrontal cortex.
“In humans, cue-induced craving appears to involve activation of similar circuits, in which cues that are associated with drugs and elements of non-drug addictions produce activation of the prefrontal cortex, including the dorsolateral prefrontal cortex, anterior cingulate gyrus, and medial orbitofrontal cortex.101–105”
Quote in the paperSubstantial claim3 of 5 sources checked- cites [101] Kober, 2016, Brain activity during cocaine craving and gambling urges: an fMRI study, Neuropsychopharmacology source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [102] Lee, 2005, A functional magnetic resonance imaging (FMRI) study of cue-induced smoking craving in virtual environments, Appl Psychophysiol Biofeedback source
- cites [103] Risinger, 2005, Neural correlates of high and craving during cocaine self-administration using BOLD fMRI, Neuroimage source
- cites [104] Volkow, 2005, Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction, J Neurosci source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [105] Jasinska, 2014, Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies, Neurosci Biobehav Rev source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
- Rests on an assumption: Neurobiological mechanisms identified in rodent models of reinstatement and craving correspond to the circuits that mediate human addiction.
- Premisecitation
Rodent evidence suggests that drug-induced reinstatement is mediated by the circuit linking the prelimbic prefrontal cortex to the ventral striatum.
“Evidence from rodent studies suggests that drug-induced reinstatement is mediated by the circuit that links the prelimbic prefrontal cortex to the ventral striatum94”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [94] McFarland, 2001, The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior, J Neurosci source
- Rests on an assumption: Neurobiological mechanisms identified in rodent models of reinstatement and craving correspond to the circuits that mediate human addiction.
- Premisecitation
Neuropeptide Y, nociceptin, and endocannabinoids act in opposition to brain stress systems.
“Key neurotransmitters that act in opposition to brain stress systems include neuropeptide Y, nociceptin, and endocannabinoids (tables 1, 2, circuits 10 and 11).”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [20] Koob, 2014, Addiction as a stress surfeit disorder, Neuropharmacology source
- cites [28] Economidou, 2011, Activation of brain NOP receptors attenuates acute and protracted alcohol withdrawal symptoms in the rat, Alcohol Clin Exp Res source
The Introduction (page not provided) says nociceptin/orphanin FQ has anti-stress effects and acts as a functional antagonist of CRF transmission. The cited paper does not establish the same claim for neuropeptide Y or endocannabinoids. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [29] Sidhpura, 2011, Endocannabinoid-mediated synaptic plasticity and addiction-related behavior, Neuropharmacology source
Section 4.2 states that endocannabinoid signaling inhibits stress-induced activation of the HPA axis, supporting the endocannabinoid part of the claim. Our copy does not establish that neuropeptide Y or nociceptin act in opposition to brain stress systems; searches for both terms found no relevant passage. No page number was provided for the section. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Human brain imaging studies report reduced cannabinoid CB1 receptors in cannabis abusers and alcoholics.
“Indeed, human brain imaging studies have reported reductions of cannabinoid CB1 receptors in cannabis abusers and alcoholics.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [86] Hirvonen, 2012, Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers, Mol Psychiatry source
The Discussion (page unavailable) reports reduced cortical CB1 receptor binding in chronic daily cannabis smokers, measured by PET. The paper does not report a comparable finding in alcoholics; its Subjects section says participants did not currently abuse drugs other than cannabis. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites [87] Ceccarini, 2014, Changes in cerebral CB1 receptor availability after acute and chronic alcohol abuse and monitored abstinence, J Neurosci source
- Premisecitation
Frontal cortex-derived executive function disorders in addiction have been linked to deficits in behavioural treatments' ability to effect recovery.
“Such frontal cortex-derived executive function disorders in addiction have been linked to deficits in the ability of behavioural treatments to effect recovery.110”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [110] Rando, 2011, Association of frontal and posterior cortical gray matter volume with time to alcohol relapse: a prospective study, Am J Psychiatry source
The Discussion (page unavailable) reports that smaller medial frontal gray matter volume predicted shorter time to relapse in alcohol-dependent patients and suggests that impaired cognitive control could contribute. It explicitly says the study did not establish a link with functional impairment; it does not assess whether executive-function deficits reduce the effectiveness of behavioural treatments. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
The capacity to inhibit prepotent responses is a major contributor to vulnerability to addiction because it modulates avoidance of inappropriate behaviours.
“The capacity to inhibit prepotent responses is a major contributor to an individual’s vulnerability to addiction because it modulates the ability to avoid inappropriate behaviours.120,121”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [120] Volkow, 2000, Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex, Cereb Cortex source
- cites [121] Volkow, 2008, Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology, Philos Trans R Soc Lond B Biol Sci source
Section 3 says that inhibiting prepotent responses is likely to help an individual refrain from taking drugs when drugs are readily available. Section 6 likewise links impaired inhibitory control to difficulty resisting drug use. The paper does not establish that this capacity is a major contributor to addiction vulnerability, and its examples concern drug use rather than inappropriate behaviours generally. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
The insula appears to have an interoceptive function integrating autonomic and visceral information with emotion and motivation, providing conscious awareness of urges.
“The insula appears to have an interoceptive function that integrates autonomic and visceral information with emotion and motivation, thus providing conscious awareness of these urges.54”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [54] Naqvi, 2009, The hidden island of addiction: the insula, Trends Neurosci source
- Premisecitation
Exposure to drug and alcohol cues activates the mTORC1 pathway in the hippocampus, frontal cortex, nucleus accumbens, and amygdala.
“Exposure to drug and alcohol cues activates the mTORC1 pathway in the hippocampus, frontal cortex, nucleus accumbens, and amygdala.149”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [149] Neasta, 2014, mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse, J Neurochem source
- Premisecitation
Next-generation sequencing shows repeated cocaine exposure leads to histone modifications that act combinatorially to create chromatin signatures altering pre-mRNA splicing, necessary for expression of cocaine-induced conditioned place preference.
“Next-generation sequencing methods have shown that repeated cocaine exposure leads to histone modifications that act in a combinational fashion to create chromatin signatures that strikingly alter pre-mRNA splicing, an effect that is necessary for the expression of cocaine-induced conditioned place preference.143”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [143] Feng, 2014, Chronic cocaine-regulated epigenomic changes in mouse nucleus accumbens, Genome Biol source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
- Premisecitation
Cravings for food, cocaine, and nicotine are related to middle insular function.
“Cravings for food, cocaine, and nicotine are also related to middle insular function.111–113”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [111] Bonson, 2002, Neural systems and cue-induced cocaine craving, Neuropsychopharmacology source
- cites [112] Pelchat, 2004, Images of desire: food-craving activation during fMRI, Neuroimage source
- cites [113] Wang, 2007, Neural substrates of abstinence-induced cigarette cravings in chronic smokers, J Neurosci source
The Regional CBF analysis of abstinence-induced craving reports that craving changes in smokers correlated with changes in right-insula blood flow, supporting the nicotine portion of the sentence. Our copy does not identify the region as the middle insula; it also does not provide evidence about food or cocaine cravings, which may be covered by the other citations. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Premisecitation
Successful cognitive inhibition of craving in cocaine abusers is associated with inhibition in the right medial orbitofrontal cortex and activation in the right inferior frontal cortex.
“Indeed, successful cognitive inhibition of craving in cocaine abusers has been associated with inhibition in the right medial orbitofrontal cortex and activation in the right inferior frontal cortex.135”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [135] Volkow, 2010, Cognitive control of drug craving inhibits brain reward regions in cocaine abusers, Neuroimage source
- Interpretationreasoning
Upregulation of postsynaptic Gs/cAMP/PKA signalling in the nucleus accumbens might be a critical neuroadaptation central to the establishment and maintenance of addiction.
“and the upregulation of a postsynaptic Gs/cAMP/PKA signalling pathway in the nucleus accumbens might constitute a critical neuroadaptation that is central to the establishment and maintenance of the addicted state.136,137”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [136] Self, 1998, Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior, J Neurosci source
The section on neuroadaptations in NAc PKA (page unavailable) says chronic drug exposure upregulates the NAc cAMP system and proposes that this may contribute to tolerance to cocaine reinforcement. It also says a role in craving and relapse is less straightforward and requires further investigation. The paper therefore supports a possible addiction-related neuroadaptation, but not the broader claim that a specifically postsynaptic Gs/cAMP/PKA pathway is central to both establishing and maintaining the addicted state. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [137] Edwards, 2010, Neurobiology of dysregulated motivational systems in drug addiction, Future Neurol source
- Premisecitation
Brain lesion studies suggest that the ventromedial prefrontal cortex and insula are necessary components of distributed circuits supporting emotional and moral decision making.
“Brain lesion studies suggest that the ventromedial prefrontal cortex and insula are necessary components of the distributed circuits that support both emotional115 and moral116 decision making.”
Quote in the paperNot a substantial claim1 of 2 sources checked - Premisecitation
An evolutionarily conserved GABA synthesis pathway mediated by ALDH1a1 has been identified in the ventral tegmental area.
“Intriguingly, an evolutionarily conserved GABA synthesis pathway mediated by aldehyde dehydrogenase 1a1 (ALDH1a1) has been identified in the ventral tegmental area.161”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [161] Kim, 2015, Aldehyde dehydrogenase 1a1 mediates a GABA synthesis pathway in midbrain dopaminergic neurons, Science source
- Premisecitation
Heavy alcohol use during adolescence is associated with impairments in visuospatial processing, attention, and memory.
“Heavy alcohol use during adolescence is associated with a range of neurobehavioural sequelae, including impairments in visuospatial processing, attention, and memory,173,174”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [173] Hanson, 2011, Impact of adolescent alcohol and drug use on neuropsychological functioning in young adulthood: 10-year outcomes, J Child Adolesc Subst Abuse source
- cites [174] Squeglia, 2009, Initiating moderate to heavy alcohol use predicts changes in neuropsychological functioning for adolescent girls and boys, Psychol Addict Behav source
- Premisenone given
Drug-induced phasic dopamine signalling can trigger neuroadaptations in basal ganglia circuits.
“Phasic dopamine signalling induced by drug administration can also trigger neuroadaptations in basal ganglia circuits.”
Quote in the paperSubstantial claim - Premisenone given
Drugs of abuse strongly affect responses to previously neutral stimuli that become paired with the drug.
“Drugs of abuse have a profound effect on the response to previously neutral stimuli to which the drugs become paired.”
Quote in the paperSubstantial claim - Interpretationnone given
In the withdrawal/negative affect stage, negative emotional states and dysphoric or stress-like responses involve reduced dopamine reward system function and recruitment of CRF and dynorphin in the extended amygdala.
“The increases in negative emotional states and dysphoric and stress-like responses in the withdrawal/negative affect stage involve decreases in the function of the dopamine component of the reward system and recruitment of brain stress neurotransmitters, such as corticotropin-releasing factor and dynorphin, in the neurocircuitry of the extended amygdala.”
Quote in the paperSubstantial claim - Premisecitation
During acute and protracted withdrawal from chronic administration of all drugs of abuse, stress and anxiety-like responses increase and contribute to abstinence malaise.
“During acute and protracted withdrawal from chronic administration of all drugs of abuse, increases in stress and anxiety-like responses also occur that contribute greatly to the malaise of abstinence and protracted abstinence (table 1).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [66] Koob, 2005, Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction, Nat Neurosci source
- Premisenone given
Drugs of abuse activate brain reward systems.
“Drugs of abuse activate brain reward systems, and research on drug addiction has in large part defined the neurocircuitry of reward.”
Quote in the paperSubstantial claim - Premisenone given
The withdrawal/negative affect stage includes chronic irritability, emotional pain, malaise, dysphoria, alexithymia, stress states, and loss of motivation for natural rewards.
“The withdrawal/negative affect stage consists of key motivational elements, such as chronic irritability, emotional pain, malaise, dysphoria, alexithymia, states of stress, and loss of motivation for natural rewards.”
Quote in the paperSubstantial claim - Interpretationnone given
Drugs of abuse usurp executive, motivational, and stress circuits through multiple neurotransmitter-specific neuroplasticity circuits.
“Drugs of abuse usurp executive function circuits, motivational circuits, and stress circuits via multiple neurotransmitter-specific neuroplasticity circuits (tables 1, 2).”
Quote in the paperSubstantial claim - Interpretationcitation
Executive function impairments mediated by the prefrontal cortex may be linked to tonic dopamine firing changes that produce lower but more stable dopamine levels in prefrontal projections.
“By contrast, parallel impairments in executive function that are mediated by the prefrontal cortex might be linked to changes in tonic dopamine cell firing that result in lower but more stable dopamine levels in the dopamine projections to the prefrontal cortex.”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationnone given
In the binge/intoxication stage, drug reward, incentive salience, and drug-seeking habits involve changes in dopamine and opioid peptides in the basal ganglia.
“The rewarding effects of drugs of abuse, development of incentive salience, and development of drug-seeking habits in the binge/intoxication stage involve changes in dopamine and opioid peptides in the basal ganglia.”
Quote in the paperNot a substantial claim - Interpretationcitation
Withdrawal/negative affect involves a between-system neuroadaptation in which neurochemical systems beyond those for positive drug reward are recruited or dysregulated by chronic reward system activation.
“The emotional dysregulation that is associated with the withdrawal/negative affect stage also involves a between-system neuroadaptation, in which neuro-chemical systems other than those involved in the positive rewarding effects of drugs of abuse are recruited or dysregulated by chronic activation of the reward system.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [68] Koob, 1988, Cellular and molecular mechanisms of drug dependence, Science source
- Premisenone given
Across major drugs of abuse, withdrawal in laboratory animals is characterised by elevated reward thresholds, indicating decreased reward.
“Across all major drugs of abuse, this stage is characterised in laboratory animals by elevations in reward thresholds (ie, decreased reward) during withdrawal.”
Quote in the paperSubstantial claim - Premisenone given
Key neurotransmitters implicated in addiction neuroadaptations include dopamine, enkephalins, glutamate, GABA, norepinephrine, CRF, dynorphin, neuropeptide Y, and endocannabinoids.
“Key neurotransmitters that are implicated in these neuroadaptations include dopamine, enkephalins, glutamate, γ-aminobutyric acid, norepinephrine, corticotropin-releasing factor (CRF), dynorphin, neuropeptide Y, and endocannabinoids (tables 1,”
Quote in the paperNot a substantial claim - Interpretationnone given
In the preoccupation/anticipation stage, craving and executive deficits involve dysregulated prefrontal cortex and insula projections, including glutamate, to the basal ganglia and extended amygdala.
“The craving and deficits in executive function in the so-called preoccupation/anticipation stage involve the dysregulation of key afferent projections from the prefrontal cortex and insula, including glutamate, to the basal ganglia and extended amygdala.”
Quote in the paperNot a substantial claim - Premisenone given
Reward circuits interact with mood regulation circuits, including stress reactivity involving the amygdala, hypothalamus, and habenula, and interoception involving the insula and anterior cingulate cortex.
“These circuits also interact with circuits that are involved in mood regulation, including stress reactivity (which involves the amygdala, hypothalamus, and habenula) and interoception (which involves the insula and anterior cingulate cortex and contributes to the awareness of negative emotional states).”
Quote in the paperNot a substantial claim - Premisecitation
Human brain imaging studies report decreased sensitivity of brain reward circuits to natural rewards during the withdrawal/negative affect stage.
“Human brain imaging studies have reported decreases in the sensitivity of brain reward circuits to stimulation by natural rewards during the withdrawal/negative affect stage.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Garavan, 2000, Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli, Am J Psychiatry source
- Interpretationnone given
Molecular genetic studies have identified transduction and transcription factors in addiction-related neurocircuitry that might mediate vulnerability, maintenance, and relapse.
“Molecular genetic studies have identified transduction and transcription factors that act in neurocircuitry associated with the development and maintenance of addiction that might mediate initial vulnerability, maintenance, and relapse associated with addiction.”
Quote in the paperNot a substantial claim - Premisecitation
The habenula is among the regions that control decreases in VTA dopamine neuron firing associated with failure to receive an expected reward.
“Numerous studies indicate that the habenula is one of the regions that control the decreases in dopamine neuron firing in the ventral tegmental area that are associated with failure to receive an expected reward.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Glutamatergic projections from the prefrontal cortex to the caudate and ventral striatum modulate the striatal-pallidal-thalamo-cortical system through direct D1 receptor-mediated and indirect D2 receptor-mediated pathways.
“Glutamatergic projections from the prefrontal cortex to the caudate and ventral striatum also modulate the control of the striatal-pallidal-thalamo-cortical system through both direct (D1 receptor-mediated) and indirect (D2 receptor-mediated) pathways.”
Quote in the paperSubstantial claim - Premisenone given
In rats, drug-induced reinstatement involves a glutamatergic projection from the prelimbic prefrontal cortex to the nucleus accumbens that is modulated by dopamine through D1 and D2 receptors in the frontal cortex.
“In rats, neurotransmitter systems that are involved in drug-induced reinstatement involve a glutamatergic projection from the prelimbic prefrontal cortex to the nucleus accumbens that is modulated by dopamine activity through D1 and D2 receptors in the frontal cortex.”
Quote in the paperSubstantial claim - Interpretationreasoning
Endogenous anti-stress systems buffer brain stress systems and influence vulnerability to the development and perpetuation of addiction.
“Endogenous anti-stress systems also appear to buffer the brain stress systems and influence vulnerability to the development and perpetuation of addiction.”
Quote in the paperSubstantial claim - Premisenone given
CRF receptor antagonists block both anxiety-like and stress-like effects of drug withdrawal and excessive drug taking during compulsive drug seeking in animals.
“Importantly, CRF receptor antagonists block both the anxiety-like, stress-like effects of drug withdrawal and excessive drug taking during compulsive drug seeking in animals.”
Quote in the paperSubstantial claim - Interpretationnone given
Increases in stress-like states and stress responsivity could be driven by recruitment of CRF in the amygdala and other extrahypothalamic stress systems.
“Increases in stress-like states and increased responsivity to stressors could be driven by the recruitment of CRF in the amygdala and other extrahypothalamic stress systems.”
Quote in the paperNot a substantial claim - Premisecitation
Protracted abstinence, largely described in alcohol dependence models, involves overactive glutamatergic and CRF systems.
“Protracted abstinence, largely described in alcohol dependence models, appears to involve overactive glutamatergic and CRF systems.99,100”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [99] De Witte, 2005, Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action, CNS Drugs source
- cites [100] Valdez, 2002, Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor, Alcohol Clin Exp Res source
- Interpretationcitation
Compulsive-like habits might derive from the dark side of the withdrawal/negative affect stage.
“Compulsive-like habits might also derive from the so-called dark side of the withdrawal/negative affect stage.”
Quote in the paperSubstantial claim - Premisereasoning
During acute withdrawal from all drugs of abuse, CRF increases in the extended amygdala.
“During acute withdrawal from all drugs of abuse, CRF increases in the extended amygdala (tables 1, 2, circuit 6).”
Quote in the paperSubstantial claim - Interpretationreasoning
Combined decreases in reward function and increases in stress function in the ventral striatum, extended amygdala, and habenula strongly trigger negative reinforcement that contributes to compulsive drug seeking and addiction.
“The combination of decreases in reward function and increases in stress function in the motivational circuits of the ventral striatum, extended amygdala, and habenula is a powerful trigger of negative reinforcement that contributes to compulsive drug-seeking behaviour and addiction.”
Quote in the paperSubstantial claim - Interpretationreasoning
Because ventral tegmental area dopamine cells project heavily to the basal ganglia, the frontal cortex glutamatergic projection might contribute to the development of incentive salience.
“Given that ventral tegmental area dopamine cells project heavily to the basal ganglia, this frontal cortex glutamatergic projection might contribute to the development of incentive salience.”
Quote in the paperSubstantial claim - Interpretationcitation
Enhanced avoidance habits provide another basis for stress axis activation contributing to compulsive-like responding.
“but the enhancement of avoidance habits provides another basis for the contribution of activation of the stress axis to compulsive-like responding.”
Quote in the paperSubstantial claim - Interpretationreasoning
Two opposing systems can be postulated: a Go system and a Stop system.
“Two opposing systems can therefore be postulated: a Go system and a Stop system.”
Quote in the paperSubstantial claim - Premisecitation
Steeper delayed discounting and cocaine craving in cocaine dependence are associated with increased connectivity in the medial prefrontal cortex-anterior cingulate-ventral striatum network and the insula-dorsal striatum network.
“For example, steeper delayed discounting and cocaine craving in cocaine dependence is associated with increased connectivity in the network linking the medial prefrontal cortex and anterior cingulate cortex with the ventral striatum and in the network linking the insula with the dorsal striatum.128”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [128] Contreras-Rodríguez, 2015, Cocaine-specific neuroplasticity in the ventral striatum network is linked to delay discounting and drug relapse, Addiction source
- Premisenone given
Genes have been identified that convey vulnerability at all three stages of the addiction cycle.
“Genes have been identified that convey vulnerability at all three stages of the addiction cycle, and salient candidates are discussed within this conceptual framework.”
Quote in the paperSubstantial claim - Premisecitation
Interventions that tonically activate nucleus accumbens cAMP/PKA signalling promote escalations in drug self-administration or compulsive-like drug-seeking behaviour.
“Numerous interventions that tonically activate nucleus accumbens cAMP/PKA signalling promote escalations in drug self-administration or compulsive-like drug-seeking behaviour”
Quote in the paperSubstantial claim - Premisecitation
Homozygosity at SNP rs1876831 C allele was associated with heavy drinking in relation to stressful life events in adolescents.
“Moreover, homozygosity at one of these single-nucleotide polymorphisms (rs1876831, C allele) was associated with heavy drinking in relation to stressful life events in adolescents.164”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [164] Blomeyer, 2008, Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use, Biol Psychiatry source
- Premisecitation
In humans, two SNPs in the CRF1 receptor gene (CRHR1) were associated with binge drinking in adolescents and excessive drinking in adults.
“From the perspective of the withdrawal/negative affect stage, in humans, two single-nucleotide poly morphisms in the CRF1 receptor gene (CRHR1) were associated with binge drinking in adolescents and excessive drinking in adults.163”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [163] Treutlein, 2006, Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples, Mol Psychiatry source
- Premisecitation
Polymorphisms in genes for cytochrome P450 2A6 and 2D6 are reportedly protective against nicotine addiction.
“Similarly, polymorphisms in the genes for cytochrome P450 2A6 and 2D6 (enzymes involved in nicotine and opioid metabolism, respectively) are reportedly protective against nicotine addiction.162”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [162] Benowitz, 2006, CYP2A6 genotype and the metabolism and disposition kinetics of nicotine, Clin Pharmacol Ther source
- Interpretationreasoning
Normal developmental processes might result in higher risk for drug use at some stages of the lifecycle than others.
“Normal developmental processes might result in higher risk for drug use at some stages of the lifecycle than others.”
Quote in the paperSubstantial claim - Premisecitation
Voluntary binge drinking in animal models during adolescence reduced density of myelinated axons in the medial prefrontal cortex.
“Additionally, voluntary binge drinking in animal models during adolescence reduced the density of myelinated axons in the medial prefrontal cortex.176”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [176] Vargas, 2014, Alcohol binge drinking during adolescence or dependence during adulthood reduces prefrontal myelin in male rats, J Neurosci source
- Premisecitation
Specific alleles for genes encoding ADH1B and ALDH2 are reportedly protective against alcoholism.
“For example, specific alleles for genes that encode alcohol dehydrogenase (ADH1B) and acetaldehyde dehydrogenase (ALDH2; enzymes involved in the metabolism of alcohol) are reportedly protective against alcoholism.160”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [160] Chen, 1999, Alcohol metabolism and cardiovascular response in an alcoholic patient homozygous for the ALDH2*2 variant gene allele, Alcohol Clin Exp Res source
- Premisenone given
Preliminary imaging data suggest common neurobiology in non-drug addictions.
“Preliminary imaging data also suggest common neurobiology.”
Quote in the paperNot a substantial claim - Premisecitation
The three stages of the addiction cycle are pervasive and form common domains in non-drug addictions such as pathological gambling, binge-eating disorder, compulsive buying, and internet addiction disorder.
“The three stages of the addiction cycle are pervasive and form common domains in non-drug addictions, also known as process addictions,179 such as pathological gambling, binge-eating disorder, compulsive buying, and internet addiction disorder.180”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [179] Smith, 2012, The process of addictions and the new ASAM definition of addiction, J Psychoactive Drugs source
- cites [180] Koob, 2013
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationnone given
Eighteen neurochemically defined mini circuits can independently or interactively load outputs of the major common neurobiological circuits to produce incentive salience and compulsive-like habits, negative emotional states of low reward and excessive stress, and compromised executive function.
“We outline 18 neurochemically defined mini circuits that can independently or interactively load the outputs of the major common neurobiological circuits to produce incentive salience and compulsive-like habits, negative emotional states of low reward and excessive stress, and compromised executive function.”
Quote in the paperSubstantial claim
- May combine two claims. 66
- Classified as probably not a substantial claim. 9
- The quote only partly states this claim. 1
May combine two claims.
PremisecitationD2 receptors inhibit cAMP signalling, are stimulated by phasic and tonic dopamine, and are not deemed necessary for drug reward.
“By contrast, D2 receptors, which inhibit cAMP signalling, are stimulated by both phasic and tonic dopamine and are not deemed necessary for drug reward.”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [40] Caine, 2002, Role of dopamine D2-like receptors in cocaine self-administration: studies with D2 receptor mutant mice and novel D2 receptor antagonists, J Neurosci source
The receptor-binding section describes dopamine agonist–mediated inhibition of cAMP accumulation, and the Discussion concludes that D2 receptors are not necessary for cocaine’s reinforcing effects in the mice studied (page numbers unavailable). The paper does not address stimulation by both phasic and tonic dopamine; it also reports that D2 receptors may be necessary for self-administration of some other drugs, so the broader claim about drug reward is not supported. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [64] Bello, 2011, Cocaine supersensitivity and enhanced motivation for reward in mice lacking dopamine D2 autoreceptors, Nat Neurosci source
The Introduction and Discussion distinguish D2 autoreceptors from D2 receptors generally. They report that mice lacking all D2 receptors have impaired or absent drug-reward responses, contrary to the claim that D2 receptors are not deemed necessary for drug reward; mice lacking only D2 autoreceptors instead show enhanced cocaine reward. The cited passages do not establish the cAMP or tonic-dopamine parts of the sentence. (LLM, conf=0.85)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationBlockade of metabotropic glutamate 1 receptors in the nucleus accumbens blocks cue-induced incubation reinstatement and cocaine-primed reinstatement, making these receptors potential therapeutic targets.
“The blockade of metabotropic glutamate 1 receptors in the nucleus accumbens blocks cue-induced incubation reinstatement and cocaine-primed reinstatement; as a result, these receptors are potential therapeutic targets.145,146”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [145] Schmidt, 2015, Group I metabotropic glutamate receptor-mediated activation of PKC γ in the nucleus accumbens core promotes the reinstatement of cocaine seeking, Addict Biol source
The Results and Discussion (pages unavailable) report that blocking mGluR1 in the accumbens core attenuated cocaine-primed reinstatement. They do not establish that it blocks cue-induced incubation reinstatement; the cue-related finding discussed concerns mGluR5. The claim also overstates attenuation as complete blockade and omits the core-specific qualification: the Introduction reports no effect of mGluR1 blockade in the accumbens shell. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [146] Loweth, 2014, Synaptic depression via mGluR1 positive allosteric modulation suppresses cue-induced cocaine craving, Nat Neurosci source
The Results section (‘The level of mGluR1 transmission regulates incubation’; page unavailable) says enhancing mGluR1 transmission prevented incubation, while mGluR1 antagonist treatment accelerated a synaptic change associated with it. The Discussion likewise proposes positive allosteric modulators—not blockade—to reduce incubated cue-induced craving. The cited paper does not report a cocaine-primed reinstatement result. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn non-human primates, midbrain dopamine cells initially fire to a novel reward, then stop firing during predictable reward delivery and fire to predictive stimuli.
“One particularly influential series of studies in non-human primates indicated that midbrain dopamine cells initially fired in response to a novel reward. After repeated exposure, the neurons stopped firing during predictable reward delivery and instead fired when they were exposed to stimuli that were predictive of the reward.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [57] Schultz, 1997, A neural substrate of prediction and reward, Science source
May combine two claims.
PremisecitationOther withdrawal changes include increased μ opioid receptor responsivity during opioid withdrawal and decreased GABAergic and increased NMDA glutamatergic transmission in the nucleus accumbens.
“Other observed changes include increases in μ opioid receptor responsivity during opioid withdrawal,71,72 and decreases in GABAergic and increases in NMDA glutamatergic transmission in the nucleus accumbens.”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [71] Stinus, 1990, Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal, Neuroscience source
- cites [72] Minkowski, 2012, Differential response to IV carfentanil in chronic cocaine users and healthy controls, Addict Biol source
The citation is attached to the claim of increased μ-opioid receptor responsivity during opioid withdrawal, not the later GABAergic/NMDA clause. The Discussion (page unavailable) examines cocaine abstinence instead and reports fewer adverse effects from a μ-opioid receptor agonist in cocaine users than in controls. A search for opioid withdrawal and receptor responsivity found no passage addressing the cited claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [73] Davidson, 1995, Increased NMDA-induced excitability during ethanol withdrawal: a behavioural and histological study, Brain Res source
May combine two claims.
PremisecitationWithdrawal involves decreased dopaminergic and serotonergic transmission in the nucleus accumbens, with striatal dopamine responses 50% lower in detoxified abusers and 80% lower in active abusers, and lower self-reported drug reward versus controls.
“Such changes include decreases in dopaminergic and serotonergic transmission in the nucleus accumbens during drug withdrawal as measured by in-vivo microdialysis in rats69 and brain imaging studies in humans, in which amphetamine-induced or methylphenidate-induced striatal dopamine responses are 50% lower in detoxified abusers and 80% lower in active abusers, and accompanied by lower self-reports”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [25] Martinez, 2007, Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine, Am J Psychiatry source
- cites [35] Volkow, 2007, Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement, J Neurosci source
The Abstract reports methylphenidate-induced dopamine responses 70% lower in ventral striatum and 50% lower in putamen in detoxified alcoholics versus controls. The Behavioral responses to MP section reports lower self-rated drug liking and high in the alcoholic group. The paper does not report an 80% reduction in active abusers; the withdrawal-related dopamine and serotonin finding appears only in the title of a rat study listed in References, not as a finding of this study. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [70] Volkow, 1997, Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects, Nature source
May combine two claims.
Premisecitationα5 nicotinic acetylcholine receptors in the habenula appear to modulate aversive responses to large doses of nicotine, and habenular α2 receptors along with α5 are involved in nicotine withdrawal.
“This hypothesis is also consistent with the finding that α5 nicotinic acetylcholine receptors in the habenula appear to modulate aversive responses to large doses of nicotine48 and, along with habenular α2 receptors, nicotine withdrawal (tables 1, 2, circuit 9).”
Quote in the paperSubstantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationImaging studies show that cocaine craving cues increase dopamine release in the striatum, amygdala, and prefrontal cortex and opioid peptides in the anterior cingulate and frontal cortex.
“Imaging studies have also revealed that cues associated with cocaine craving increase dopamine release in the striatum, amygdala, and prefrontal cortex (anterior cingulate and medial orbitofrontal cortex) and opioid peptides in the anterior cingulate and frontal cortex.9,31,106,107”
Quote in the paperSubstantial claim2 of 4 sources checked- cites [9] Koob, 2010, Neurocircuitry of addiction, Neuropsychopharmacology source
The Ventral Striatum/Dorsal Striatum/Thalamus section (page not provided) reports that drug-associated cues increase dopamine in the dorsal striatum and that the increase correlates with craving. It also links the amygdala and prefrontal cortex to cue-induced craving, but does not report cue-induced dopamine release in those regions. The cited passages do not support increased opioid peptides in the anterior cingulate or frontal cortex. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [31] Fotros, 2013, Cocaine cue-induced dopamine release in amygdala and hippocampus: a high-resolution PET [18F]fallypride study in cocaine dependent participants, Neuropsychopharmacology source
- cites [106] Volkow, 2006, Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction, J Neurosci source
- cites [107] Milella, 2016, Cocaine cue-induced dopamine release in the human prefrontal cortex, J Psychiatry Neurosci source
The Results and Discussion report cocaine cue-associated dopamine release in the striatum and prefrontal cortex, strongest in the medial orbitofrontal cortex, with a threshold response in the anterior cingulate. The paper does not report its own amygdala dopamine finding, though its References name a separate study on that region; a search for opioid peptides found no supporting passage. Thus it supports only part of the sentence attributed to it. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIn patients with obsessive-compulsive disorder, overtraining on a shock avoidance task produced enhanced avoidance habits compared with controls, supporting a habit account of obsessive-compulsive disorder.
“In a study of patients with obsessive-compulsive disorder, patients showed enhanced avoidance habits compared with controls following overtraining on a shock avoidance task, providing support for a habit account of obsessive-compulsive disorder.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [83] Gillan, 2014, Enhanced avoidance habits in obsessive-compulsive disorder, Biol Psychiatry source
May combine two claims.
InterpretationcitationDecreases in nucleus accumbens dopamine release can be driven by increased dynorphin-κ opioid receptor activity in the ventral striatum and possibly increased CRF in the VTA, contributing to negative emotional states in withdrawal and protracted abstinence.
“Decreases in the release of dopamine in the nucleus accumbens can also be driven by increases in the activity of the dynorphin-κ opioid receptor system in the ventral striatum and possibly increases in the activity of CRF in the ventral tegmental area, which contributes to the negative emotional state associated with withdrawal and protracted abstinence.”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [20] Koob, 2014, Addiction as a stress surfeit disorder, Neuropharmacology source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [21] Carlezon, 2000, Herpes simplex virus-mediated gene transfer as a tool for neuropsychiatric research, Crit Rev Neurobiol source
May combine two claims.
PremisecitationIn rats, the prefrontal cortex sends glutamatergic projections directly to mesocortical dopamine neurons in the ventral tegmental area, exerting excitatory control over dopamine cell firing and dopamine release in the prefrontal cortex.
“In rats, the prefrontal cortex (mainly prelimbic cortex, and some infralimbic cortex) sends glutamatergic projections directly to mesocortical dopamine neurons in the ventral tegmental area, thus exerting excitatory control over dopamine cell firing and dopamine release in the prefrontal cortex90”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [90] Geisler, 2008, Functional implications of glutamatergic projections to the ventral tegmental area, Rev Neurosci source
Section 2.3 describes a predominantly glutamatergic projection from the prefrontal cortex to the VTA, concentrated in prelimbic cortex with a lesser contribution from infralimbic cortex, and says its axons synapse onto mesocortical dopamine neurons. The Introduction reports that activation of an excitatory prefrontal-to-VTA pathway induces dopamine-neuron burst firing. But the functional-anatomy discussion also emphasizes indirect pathways and inhibition of many dopamine neurons; our copy does not establish the claimed excitatory control of dopamine release specifically in the prefrontal cortex. (LLM, conf=0.88)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationVolkow and Goldstein described a syndrome characterized by excessive salience to drug-paired cues, decreased responsiveness to non-drug rewards, and decreased ability to inhibit maladaptive behaviour.
“Indeed, Volkow and colleagues36 and Goldstein and Volkow14 have described a syndrome that is characterised by excessive salience to drug-paired cues, decreases in the responsiveness to non-drug rewards, and decreases in the ability to inhibit maladaptive behaviour.”
Quote in the paperNot a substantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationAlcohol use during adolescence might lead to epigenetic modifications that alter amygdalar gene expression and dendritic density, increasing susceptibility to anxiety-like behaviours and alcohol ingestion in adulthood.
“alcohol use during adolescence might lead to epigenetic modifications that alter amygdalar gene expression and dendritic density, increasing susceptibility to anxiety-like behaviours and alcohol ingestion in adulthood.140”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [140] Pandey, 2015, Potential role of adolescent alcohol exposure-induced amygdaloid histone modifications in anxiety and alcohol intake during adulthood, Neurobiol Dis source
May combine two claims.
PremisecitationBlockade of mTORC1 systemically blocked reconsolidation of cocaine memories, and blockade in the amygdala blocked reconsolidation of alcohol memories, suggesting a potential molecular target for relapse treatment.
“Even more compelling, blockade of the mTORC1 pathway systemically blocked the reconsolidation of cocaine memories,150 and blockade of mTORC1 in the amygdala blocked the reconsolidation of alcohol memories;151 these results suggest a potential molecular target for the treatment of relapse.”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [150] Shi, 2014, Reactivation of cocaine reward memory engages the Akt/GSK3/mTOR signaling pathway and can be disrupted by GSK3 inhibition, Psychopharmacology (Berl) source
The Methods and Results report that systemic injection of the GSK3 inhibitor SB216763 after memory reactivation disrupted reconsolidation of cocaine reward memory. They do not report systemic blockade of mTORC1; the Discussion describes reduced mTORC1 phosphorylation after memory reactivation, not an mTORC1-blockade experiment. The alcohol-memory finding has a separate citation in the citing sentence and is not attributed to this paper. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [151] Barak, 2013, Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse, Nat Neurosci source
May combine two claims.
PremisecitationImaging studies report differential activation of the insula during craving, possibly reflecting interoceptive cues and hypothesised to involve CRF activation.
“Consistent with this hypothesis, imaging studies have reported differential activation of the insula during craving, possibly reflecting interoceptive cues and hypothesised to involve CRF activation (table 2, circuit 18).54,117,118”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [54] Naqvi, 2009, The hidden island of addiction: the insula, Trends Neurosci source
The Evidence for the role of the insula in addiction section reports imaging activation of the insula during drug urges, and the Proposed role section links those urges to interoceptive representations. The Anatomy and function section notes CRF receptors in the insula and a possible role in stress-related motivation to take drugs, but it does not link the reported imaging activation during craving to CRF activation. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [117] Sánchez, 1999, Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain, J Comp Neurol source
- cites [118] Goudriaan, 2010, Brain activation patterns associated with cue reactivity and craving in abstinent problem gamblers, heavy smokers and healthy controls: an fMRI study, Addict Biol source
The Results (fMRI cue reactivity; page unavailable) report a positive association between gambling craving and left anterior insula activation, supporting the insula–craving portion of the claim. The passages do not link that activation to interoceptive cues or hypothesise CRF activation. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationDuring incubation of craving in animal models, AMPA-type glutamate receptors are recruited: the infralimbic medial prefrontal cortex-to-nucleus accumbens shell circuit recruits calcium-permeable AMPA receptors, and the prelimbic medial prefrontal cortex-to-nucleus accumbens core circuit recruits non-calcium-permeable AMPA receptors.
“Specifically, the infralimbic medial prefrontal cortex-to-nucleus accumbens shell circuit recruits calcium-permeable AMPA receptors,144 and the prelimbic medial prefrontal cortex-to-nucleus accumbens core circuit recruits non-calcium-permeable AMPA receptors.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [144] Conrad, 2008, Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving, Nature source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationThe Go system could drive craving and engage habits via the basal ganglia.
“The Go system could drive craving and engage habits via the basal ganglia.105,127”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [105] Jasinska, 2014, Factors modulating neural reactivity to drug cues in addiction: a survey of human neuroimaging studies, Neurosci Biobehav Rev source
- cites [127] Niendam, 2012, Meta-analytic evidence for a superordinate cognitive control network subserving diverse executive functions, Cogn Affect Behav Neurosci source
The Discussion (page unavailable) reports caudate and putamen activation in executive-function tasks, but does not connect those regions to a Go system, craving, or habits. Searches for those terms and for basal-ganglia, striatal, reward, and motivational mechanisms found no passage addressing the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationMethamphetamine-dependent individuals with striatal D2 receptor availability in the normal range had better treatment outcomes, potentially reflecting greater ability to acquire new reward-related behaviours and pursue healthy goals.
“Methamphetamine-dependent individuals with striatal D2 receptor availability within the normal range had better treatment outcomes, potentially reflecting a greater ability to acquire new reward-related behaviours and the pursuit of healthy goals.126”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [126] Wang, 2012, Decreased dopamine activity predicts relapse in methamphetamine abusers, Mol Psychiatry source
May combine two claims.
InterpretationcitationThe Stop system could control assessment of the incentive value of choices and suppression of affective responses to negative emotional signals.
“The Stop system could control assessment of the incentive value of choices and suppression of affective responses to negative emotional signals.130–132”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [130] Damasio, 1996, The somatic marker hypothesis and the possible functions of the prefrontal cortex, Philos Trans R Soc Lond B Biol Sci source
- cites [131] Bechara, 1999, Different contributions of the human amygdala and ventromedial prefrontal cortex to decision-making, J Neurosci source
- cites [132] Johnstone, 2007, Failure to regulate: counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression, J Neurosci source
The Introduction and Materials and Methods (page unavailable) describe top-down regulation and attempts to suppress emotional responses to negative pictures. The paper does not address a “Stop system” assessing the incentive value of choices, so that part of the claim is unsupported. (LLM, conf=0.85)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationTobacco smokers with insula damage, but not control smokers with extra non-insular lesions, were able to stop smoking easily without cravings or relapse.
“Tobacco smokers with damage to the insula (but not control smokers with extra non-insular lesions) were able to stop smoking easily and without experiencing cravings or relapse.114”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [114] Naqvi, 2007, Damage to the insula disrupts addiction to cigarette smoking, Science source
The paper’s results (section labelled Abstract; page unavailable) report that 12 of 13 smokers who quit after insula damage met criteria including easy quitting, no relapse, and no subsequent urges, compared with 4 of 19 quitters with non-insular lesions. The contrast is supported, but “not control smokers” is too absolute: four controls also met those criteria, and not every smoker with insula damage quit. (LLM, conf=0.90)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationLow striatal D2 receptor levels are associated with decreased baseline glucose metabolism in the prefrontal cortex, impulsivity in methamphetamine abusers, and compulsive cocaine administration in rodents.
“These low levels of striatal D2 receptors have been associated with decreases in baseline glucose metabolism (ie, a marker of brain function) in the prefrontal cortex (including dorsolateral prefrontal cortex, anterior cingulate gyrus, and medial orbitofrontal cortex),35,123,124 impulsivity in methamphetamine abusers,125 and compulsive cocaine administration in rodents.15”
Quote in the paperSubstantial claim2 of 5 sources checked- cites [35] Volkow, 2007, Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement, J Neurosci source
The Results section reports that baseline striatal D2/D3 receptor availability correlated with glucose metabolism in the cingulate gyrus and dorsolateral prefrontal cortex in detoxified alcoholics, but not controls. It does not report a baseline-receptor correlation with medial orbitofrontal metabolism; its orbitofrontal finding concerns methylphenidate-induced dopamine changes. The later impulsivity and rodent clauses have separate citations and are not attributed to this source. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [123] Volkow, 1993, Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers, Synapse source
- cites [124] Volkow, 2001, Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex, Am J Psychiatry source
- cites [125] Lee, 2009, Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity, J Neurosci source
- cites [15] Everitt, 2008, Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction, Philos Trans R Soc Lond B Biol Sci source
May combine two claims.
PremisecitationIn animal models, dopamine D1 receptor knockout rats will not self-administer cocaine and μ opioid receptor knockout mice will not show rewarding effects of opioids.
“Notably, in animal models, dopamine D1 receptor knockout rats will not self-administer cocaine37 and μ opioid receptor knockout mice will not show the rewarding effects of opioids.153”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [37] Caine, 2007, Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice, J Neurosci source
The Abstract and Discussion report that dopamine D1 receptor knock-out mice did not reliably self-administer cocaine. The citing sentence says rats, but this study tested mice. The separate claim about μ opioid receptor knock-out mice is attached to a different citation and is not assessed here. (LLM, conf=0.90)
Experimental — accuracy not yet measured - cites [153] Matthes, 1996, Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene, Nature source
May combine two claims.
PremisecitationmTORC1 plays a major role in molecular mechanisms of learning and memory and is involved in epilepsy, Parkinson's disease, Alzheimer's disease, and addiction.
“As such, mTORC1 plays a major role in the molecular mechanisms associated with learning and memory147 and is involved in several brain disorders, including epilepsy, Parkinson’s disease, Alzheimer’s disease, and addiction.148,149”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [147] Costa-Mattioli, 2009, Translational control of long-lasting synaptic plasticity and memory, Neuron source
- cites [148] Costa-Mattioli, 2013, mTOR complexes in neurodevelopmental and neuropsychiatric disorders, Nat Neurosci source
- cites [149] Neasta, 2014, mTOR complex 1: a key player in neuroadaptations induced by drugs of abuse, J Neurochem source
May combine two claims.
PremisecitationPET studies show substantial reductions of D2 receptor availability in the striatum in individuals with addiction that persist for months after protracted detoxification, also observed in rodents and non-human primates with repeated drug exposure.
“Positron emission tomography studies have uncovered substantial reductions of D2 receptor availability in the striatum in individuals with addiction that persist for months after protracted detoxification, which have also been observed in preclinical studies in rodents and non-human primates with repeated drug exposure.122”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [122] Volkow, 2009, Imaging dopamine's role in drug abuse and addiction, Neuropharmacology source
Split into 2 atoms — 1 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationThe field has excellent and validated animal models and well developed clinical models that, combined with neurocircuitry analysis, will provide a unique approach to medication development emphasizing excessive incentive salience, loss of brain reward function, gain of stress function driving negative reinforcement, and dysregulation of executive function, key components driving compulsive drug寻求.
“Our contention is that the field of the neurobiology of addiction has excellent and validated animal models and well developed clinical models that, combined with the neurocircuitry analysis herein, will provide a unique approach to medication development that emphasises excessive incentive salience, the loss of brain reward function, and the gain of stress function that drive negative reinfor”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [13] Koob, 2016, Existing and future drugs for the treatment of the dark side of addiction, Annu Rev Pharmacol Toxicol source
- cites [185] Koob, 2009, Development of pharmacotherapies for drug addiction: a Rosetta stone approach, Nat Rev Drug Discov source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationDrug exposure during adolescence is associated with more chronic and intensive use and greater risk of substance use disorder than initiation at older ages.
“Drug exposure during adolescence is associated with more chronic and intensive use and greater risk of a substance use disorder than is initiation at older ages.167,169–172”
Quote in the paperSubstantial claim1 of 5 sources checked- cites [167] Spear, 2013, Adolescent neurodevelopment, J Adolesc Health source
In “Broad implications of recent research for adolescent policy and programs” (page unavailable), the paper says adolescent responses to rewards may encourage continued and escalating drug use and lead to problematic involvement. It does not establish that people first exposed during adolescence have more chronic or intensive use, or a greater risk of substance use disorder, than people who initiate at older ages. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [169] Grant, 2001, Age at onset of alcohol use and DSM-IV alcohol abuse and dependence: a 12-year follow-up study, J Subst Abuse source
- cites [170] Volkow, 2006, Altered pathways: drug abuse and age of onset, Addict Professional
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [171] Hingson, 2006, Age of alcohol-dependence onset: associations with severity of dependence and seeking treatment, Pediatrics source
- cites [172] King, 2007, A prospective study of the effects of age of initiation of alcohol and drug use on young adult substance dependence, J Stud Alcohol Drugs source
Probably not a substantial claim: may not pass S2 (checkable).
InterpretationcitationAdvances in diagnosis reflecting endophenotype or research domain criterion approach will synergistically combine with advances in neurobiology to promote novel pharmacotherapeutic, brain stimulation, and behavioural treatments.
“Advances in diagnosis that reflect such an endophenotype or research domain criterion approach will synergistically combine with advances in neurobiology to promote novel pharmacotherapeutic, brain stimulation (ie, transcranial magnetic stimulation and direct electrical stimulation), and behavioural treatments.186”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [186] Kwako, 2015, Addictions neuroclinical assessment: a neuroscience-based framework for addictive disorders, Biol Psychiatry source
The Introduction’s “Changes in Nosology” section says that a mechanistically informed approach to diagnosis may identify improved treatments and better match patients to them; it discusses both medications and behavioural treatments. It does not support the more definite prediction that diagnostic and neurobiological advances will synergistically produce novel treatments, and the passages found do not address brain stimulation. Page numbers are unavailable in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationA genetic knock-in mouse recapitulating human FAAH mutation C385A presented reduced FAAH expression associated with the variant allele that selectively enhanced fronto-amygdala connectivity and fear extinction learning and decreased anxiety-like behaviours, suggesting a possible molecular genetic target.
“From the perspective of the preoccupation/anticipation stage, a genetic knock-in mouse that bio logically recapitulates a common human mutation in the gene for fatty acid amide hydrolase (C385A [Pro129Thr], rs324420) presented a reduction of fatty acid amide hydrolase expression associated with the variant allele that selectively enhanced fronto-amygdala connectivity and fear extinction learning”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [165] Dincheva, 2015, FAAH genetic variation enhances fronto-amygdala function in mouse and human, Nat Commun source
May combine two claims.
PremisecitationExperimentation and addiction most often start in adolescence, a period of important brain developmental changes.
“Experimentation, as well as the process of addiction, most often starts in adolescence,166 a period during which the brain undergoes important developmental changes.167”
Quote in the paperSubstantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationNormal adolescent-specific behaviours such as risk-taking, novelty-seeking, and high sensitivity to peer pressure increase propensity to experiment with legal and illegal drugs, possibly reflecting incomplete development of brain regions involved in executive control and motivation.
“Normal adolescent-specific behaviours (eg, risk-taking, novelty-seeking, and high sensitivity to peer pressure) increase the propensity to experiment with legal and illegal drugs,167 which might reflect the incomplete development of brain regions (eg, myelination of frontal lobe regions) that are involved in the processes of executive control and motivation.168”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [167] Spear, 2013, Adolescent neurodevelopment, J Adolesc Health source
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [168] Giedd, 1999, Brain development during childhood and adolescence: a longitudinal MRI study, Nat Neurosci source
May combine two claims.
PremisecitationMechanisms responsible for stress-induced increases in vulnerability to drug use and relapse are not well understood, but evidence suggests CRF is involved through effects in the amygdala and hypothalamic-pituitary-adrenal axis.
“The mechanisms that are responsible for stress-induced increases in vulnerability to drug use and relapse in those who are addicted are not yet well understood, but evidence suggests that the stress-responsive neuropeptide CRF is involved through its effects in the amygdala and hypothalamic-pituitary-adrenal axis.20”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [20] Koob, 2014, Addiction as a stress surfeit disorder, Neuropharmacology source
May combine two claims.
PremisecitationGWAS implicated α4 and α5 nicotinic receptor subunits in vulnerability to nicotine dependence and a SNP regulating trafficking and gating of AMPA-selective glutamate receptors (CNIH3) in opioid dependence.
“For example, genome-wide association studies have implicated two acetylcholine receptors, the α4 nicotinic receptor subunit157 and α5 nicotinic receptor subunit,158 in the vulnerability to nicotine dependence and a single-nucleotide polymorphism associated with regulating the trafficking and gating properties of AMPA-selective glutamate receptors (CNIH3) in opioid dependence.159”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites [157] Hancock, 2015, Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependence, Transl Psychiatr source
- cites [158] Olfson, 2016, Rare, low frequency and common coding variants in CHRNA5 and their contribution to nicotine dependence in European and African Americans, Mol Psychiatry source
- cites [159] Nelson, 2016, Evidence of CNIH3 involvement in opioid dependence, Mol Psychiatry source
The Results (Confirmation of association findings) report genome-wide significant associations between CNIH3 SNPs and opioid dependence, while the Discussion describes CNIH3 as an AMPA-receptor auxiliary protein that affects receptor deactivation and desensitization. The paper does not establish that an associated SNP itself regulates AMPA-receptor trafficking or gating. Citation 159 is attached to the opioid-dependence clause, not the separate nicotine-dependence claims. (LLM, conf=0.83)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationD3 receptors are high-affinity dopamine receptors that co-localise with D1 receptors in the nucleus accumbens and are associated with drug-seeking behaviour.
“D3 receptors, which are high-affinity dopamine receptors and co-localise in the nucleus accumbens with D1 receptors, are also associated with drug-seeking behaviour.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [65] Vorel, 2002, Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats, J Neurosci source
May combine two claims.
PremisecitationImpulsivity and compulsivity can coexist and often do so across different stages of the addiction cycle.
“However, impulsivity and compulsivity can coexist, and frequently do so in the different stages of the addiction cycle.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [8] Berlin, 2014, Compulsivity, impulsivity, and the DSM-5 process, CNS Spectr source
May combine two claims.
Premisenone givenNo animal model fully reproduces human addiction, but animal models permit investigation of specific signs or symptoms of the condition.
“Although no animal model of addiction fully emulates the human condition, they permit investigations of specific signs or symptoms that are associated with the psychopathological condition.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationDifferential regional changes in nicotinic receptor function in the nucleus accumbens and ventral tegmental area occur in nicotine, alcohol, and other addictions, implicating α4β2 nicotinic receptor subtypes.
“Differential regional changes in nicotinic receptor function in the nucleus accumbens and ventral tegmental area in nicotine, alcohol, and other addictions have also been reported, implicating α4β2 nicotinic receptor subtypes.”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
InterpretationcitationAddiction can be conceptualised as a recurring three-stage cycle-binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation-that worsens over time and involves neuroplastic changes in reward, stress, and executive function systems.
“Addiction can be conceptualised as a three-stage, recurring cycle—binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation (craving)—that worsens over time and involves neuroplastic changes in the brain reward, stress, and executive function systems.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [4] Koob, 1997, Drug abuse: hedonic homeostatic dysregulation, Science source
- cites [5] Goldstein, 2002, Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex, Am J Psychiatry source
- cites [6] Baumeister, 1994
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Interpretationnone givenAddiction involves a severe disruption of motivational circuits caused by exaggerated incentive salience and habit formation, reward deficits and stress surfeits, and impaired executive function across three stages.
“Drug addiction represents a dramatic dysregulation of motivational circuits that is caused by a combination of exaggerated incentive salience and habit formation, reward deficits and stress surfeits, and compromised executive function in three stages.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationcitationVentral striatum activation recruits striatal-globus pallidal-thalamocortical loops that engage the dorsal striatum, producing habit formation and possibly compulsive drug responding.
“Activation of the ventral striatum leads to the recruitment of striatal-globus pallidalthalamocortical loops that engage the dorsal striatum, resulting in habit formation45 and triggering what is hypothesised to underlie compulsive responding for drugs (table 2, circuits 3 and 4).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [45] Belin, 2009, Parallel and interactive learning processes within the basal ganglia: relevance for the understanding of addiction, Behav Brain Res source
- cites [59] Belin, 2008, Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum, Neuron source
May combine two claims.
InterpretationreasoningLower-affinity D1 receptors, which stimulate cAMP signalling, are involved in acute drug reward and conditioning because both induce dopamine spikes.
“This mechanism implicates lower-affi nity D1 receptors, which stimulate cyclic adenosine monophosphate (cAMP) signalling, as being involved in both acute drug reward and conditioning, because both induce spikes in dopamine release.”
Quote in the paperSubstantial claimMay combine two claims. The quote only partly states this claim.
PremisereasoningDrug reward circuitry includes many neural inputs and outputs interacting with the basal forebrain, involving dopamine, opioid peptides, GABA, glutamate, serotonin, acetylcholine, and endocannabinoids at the VTA or nucleus accumbens.
“The specific circuitry that is associated with drug reward has been broadened to include many neural inputs and outputs that interact with the basal forebrain.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationA new reward and later its associated cues trigger phasic dopamine cell firing and D1 receptor activation, which is necessary for conditioning.
“A new reward—and subsequently the cues associated with the reward—triggered phasic dopamine cell firing and activation of dopamine D1 receptors, which are necessary for conditioning to occur (table 2, circuits 1–4).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [58] Ungless, 2001, Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons, Nature source
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenBalanced circuits produce proper inhibitory control, decision making, and normal reward, motivation, stress, and memory function.
“Balanced circuits result in proper inhibitory control and decision making and normal functioning of reward, motivation, stress, and memory circuits.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningConditioned reinforcement and incentive salience are constructs underlying cue-induced drug seeking, self-administration, and possibly the transition to habit-like compulsive drug seeking.
“Both conditioned reinforcement and incentive salience provide constructs for what underlies cue-induced drug seeking, self-administration behaviours, and, conceivably, the transition to habit-like compulsive drug seeking.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningConditioned cues recruiting these circuits augment progression through the addiction cycle and help explain craving and compulsive use during exposure to drug cues or stressful environments linked to negative emotional states.
“The ability of conditioned cues to recruit these circuits augments progression through the addiction cycle and helps explain intense desire for the drug (ie, craving) and compulsive use when individuals with addiction are exposed to drug cues or stressful environments that are linked with negative emotional states.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIndividuals shift from impulsivity to compulsivity, and drug-taking motivation shifts from positive to negative reinforcement.
“In this context, individuals move from impulsivity to compulsivity, and the drive for drug-taking behaviour is paralleled by shifts from positive to negative reinforcement (figure 1).”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningThis process endows previously neutral stimuli with incentive salience and strengthens learned associations, creating strong motivation to seek reward.
“This process allows previously neutral stimuli to become endowed with incentive salience and strengthens the learned association with repeated exposure to the cues, which creates strong motivation to seek a reward.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationThe anti-reward concept proposes that opponent processes general to biological systems act to limit reward.
“As a result, the concept of anti-reward was developed,2 based on the proposal that opponent processes that are a general feature of biological systems also act to limit reward.”
Quote in the paperSubstantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenThe within-system and between-system construct may also apply to the preoccupation/anticipation stage.
“Thus, the within-system and between-system construct could be equally valid for the preoccupation/anticipation stage.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationCraving is difficult to measure in human clinical studies and does not always correlate with relapse.
“craving in itself has been diffi cult to measure in human clinical studies and does not always correlate with relapse.89”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [89] Tiffany, 2000, Challenges in the manipulation, assessment and interpretation of craving relevant variables, Addiction source
May combine two claims.
PremisecitationThese aversive states appear when the drug is removed during acute withdrawal and also during protracted abstinence.
“These aversive states are manifest when the drug is removed during acute withdrawal but also during protracted abstinence.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Koob, 2008, Addiction and the brain antireward system, Annu Rev Psychol source
May combine two claims.
PremisecitationImaging studies show baseline decreases in orbitofrontal and anterior cingulate function and dopamine function during dependence, with reactivation of dopamine and reward system function during acute craving episodes.
“Indeed, imaging studies have revealed baseline decreases in orbitofrontal (medial and lateral) and anterior cingulate (ventral and dorsal) function and dopamine function during dependence, but reactivation of dopamine and reward system function during acute craving episodes.108”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [108] Volkow, 1999, Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction, Am J Psychiatry source
May combine two claims.
Interpretationnone givenDecreases in reward can be driven by overactivation of the habenula or overactivation of the ventral striatal dynorphin system, both of which can decrease dopamine neuron firing.
“Decreases in reward can be driven by overactivation of the habenula or overactivation of the dynorphin system in the ventral striatum, both of which can decrease dopamine neuron firing.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationAnti-reward circuits are engaged as neuroadaptations during addiction development and produce aversive or stress-like states.
“Anti-reward circuits are engaged as neuroadaptations during the development of addiction, producing aversive or stress-like states.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] Koob, 2008, Addiction and the brain antireward system, Annu Rev Psychol source
May combine two claims.
PremisecitationCue-induced reinstatement involves a glutamatergic projection from the prelimbic prefrontal cortex, basolateral amygdala, and ventral subiculum to the nucleus accumbens, and dopamine modulation in the basolateral amygdala and dorsal striatum.
“Cue-induced reinstatement also involves a glutamatergic projection from the prelimbic prefrontal cortex, basolateral amygdala, and ventral subiculum to the nucleus accumbens, and dopamine modulation in the basolateral amygdala and dorsal striatum (tables 1, 2, circuits 14 and 15).51,52,95”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [51] Vorel, 2001, Relapse to cocaine-seeking after hippocampal theta burst stimulation, Science source
- cites [52] Everitt, 2002, Psychomotor stimulant addiction: a neural systems perspective, J Neurosci source
- cites [95] Vanderschuren, 2005, Involvement of the dorsal striatum in cue-controlled cocaine seeking, J Neurosci source
May combine two claims.
PremisecitationIn PTSD there is substantial evidence of hypoactivity in the ventromedial prefrontal cortex and hyperactivity in the central nucleus of the amygdala, reflecting an inhibitory connection between them.
“For example, in post-traumatic stress disorder there is substantial evidence of hypoactivity in the ventromedial prefrontal cortex and hyperactivity in the central nucleus of the amygdala that reflects an inhibitory connection between the ventromedial prefrontal cortex and central nucleus of the amygdala.133,134”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationActivation of the dorsal anterior cingulate is associated with fear conditioning in post-traumatic stress disorder.
“Activation of the dorsal anterior cingulate is also associated with fear conditioning in post-traumatic stress disorder.129”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [129] Bryant, 2005, Neural networks of information processing in posttraumatic stress disorder: a functional magnetic resonance imaging study, Biol Psychiatry source
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenNeuroplastic changes are triggered and sustained by molecular and cellular adaptations that can presumably interact with genetic and environmental vulnerability to addiction.
“The neuroplastic changes outlined previously are triggered and sustained by molecular and cellular adaptations that can presumably also interact with genetic and environmental vulnerability to addiction.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisenone givenmTORC1 belongs to the PIKK family and plays a key role in dendritic translation of synaptic proteins.
“The kinase mammalian (mechanistic) target of rapamycin complex 1 (mTORC1) belongs to the phosphoinositide 3-kinase (PI3K)-related kinase (PIKK) family and plays a key role in the dendritic translation of synaptic proteins.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningUnder this framework, a Stop system would inhibit the Go craving system and stress system.
“Under this framework, a Stop system would inhibit the Go craving system and stress system.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIntroduction of CREB in the nucleus accumbens decreases the reinforcing value of natural and drug rewards, plausibly contributing to withdrawal/negative affect stage-related decreases in reward pathway function and an amotivational, dysphoric, or depressed-like state.
“Introduction of cAMP response element binding protein in the nucleus accumbens decreases the reinforcing value of natural and drug rewards, and this change plausibly contributes to withdrawal/negative affect stage-related decreases in reward pathway function, which leave a drug-abstinent individual in an amotivational, dysphoric, or depressed-like state.138,139”
Quote in the paperSubstantial claim0 of 2 sources checkedClassified as probably not a substantial claim. May combine two claims.
PremisecitationRepeated substance use activates accumulating levels of ΔFosB, and animals with elevated ΔFosB exhibit exaggerated sensitivity to rewarding effects of drugs, leading to the hypothesis that ΔFosB might be a sustained molecular trigger or switch that helps initiate and maintain addiction.
“For example, repeated substance use activates accumulating levels of ΔFosB, and animals with elevated ΔFosB exhibit exaggerated sensitivity to the rewarding effects of drugs of abuse, leading to the hypothesis that ΔFosB might be a sustained molecular trigger or switch that helps initiate and maintain a state of addiction.141,142”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationIn humans, only a few specific genes have been identified with polymorphisms that predispose or protect from drug addiction, but the number is growing.
“In humans, only a few specific genes have been identified with polymorphisms (alleles) that either predispose an individual to or protect an individual from drug addiction,156 but the number is growing.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [156] Uhl, 2004, The burden of complex genetics in brain disorders, Arch Gen Psychiatry source
May combine two claims.
PremisecitationHeritability of addictions is 40-60%, much caused by genetic variations affecting underlying neurobiological mechanisms, consistent with common pathways to different addictions.
“Heritability of addictions is 40–60%, much of which is caused by genetic variations that affect underlying neurobiological mechanisms, and thus is consistent with there being common pathways to different addictions.152”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [152] Lerman, 2003, Elucidating the role of genetic factors in smoking behavior and nicotine dependence, Am J Med Genet B Neuropsychiatr Genet source
May combine two claims.
Premisenone givenChronic exposure to a wide variety of abused drugs upregulates cAMP formation, PKA activity, and PKA-dependent protein phosphorylation in the nucleus accumbens.
“For example, chronic exposure to a wide variety of abused drugs upregulates cAMP formation, cAMP-dependent protein kinase A (PKA) activity, and PKA-dependent protein phosphorylation in the nucleus accumbens.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenChronic exposure to various drugs of abuse increases activation of cAMP response element binding protein in the nucleus accumbens and deactivates it in the central nucleus of the amygdala.
“A well characterised example is that chronic exposure to various drugs of abuse increases the activation of cAMP response element binding protein in the nucleus accumbens and deactivates it in the central nucleus of the amygdala.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationGABA co-release is modulated by binge-like doses of alcohol in mice, and diminished ALDH1a1 leads to enhanced alcohol consumption and preference.
“GABA co-release is modulated by binge-like doses of alcohol administered to mice, and diminished ALDH1a1 leads to enhanced alcohol consumption and preference.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningAlthough such approaches do not guarantee genes convey vulnerability in humans, they provide viable candidates for exploring genetic basis of endophenotypes associated with addiction.
“Although such approaches do not guarantee that these genes convey vulnerability in the human population, they provide viable candidates for exploring the genetic basis of endophenotypes that are associated with addiction.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationnone givenIdentification of molecular and neurochemical loads on the circuitry provides key information about vulnerability, resilience, treatment, recovery from addiction, and how different drugs enter the addiction cycle.
“Identification of these molecular and neurochemical loads on the circuitry provides key information about vulnerability, resilience, treatment, and recovery from addiction, as well as information on how different drugs of abuse enter the overall addiction cycle.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationBeginning in preadolescence and continuing into the mid-20s, cortical grey matter volumes reduce reflecting normal pruning; white matter volume increases over adolescence reflecting increased connectivity including axonal extension and myelination.
“Beginning in preadolescence and continuing into the mid-20s, cortical grey matter volumes reduce, which reflects a normal pruning process;168 white matter volume increases over the course of adolescence, reflecting increases in connectivity, including axonal extension and myelination.168”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [168] Giedd, 1999, Brain development during childhood and adolescence: a longitudinal MRI study, Nat Neurosci source
May combine two claims.
PremisereasoningNon-drug addictions elaborate self-regulation failures similarly to drug addictions, with transitions from impulsivity to compulsivity and a chronic relapsing trajectory.
“Non-drug addictions elaborate self-regulation failures similarly to drug addictions, with transitions from impulsivity to compulsivity and a chronic relapsing trajectory.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based).
Premisenone givenNon-drug addictions such as pathological gambling have a similar behavioural phenotype that fits into the three-stage cycle.
“Non-drug addictions, such as pathological gambling, have a similar behavioural phenotype that fits into the three-stage cycle.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationEnvironmental factors consistently associated with propensity to self-administer drugs include structural factors such as low socioeconomic status and lack of social support, proximal factors such as parental drug use, poor parenting, parental depression, and sibling and peer influences, and distal factors such as drug availability, school, neighbourhood, advertising, and media.
“Environmental factors that have been consistently associated with the propensity to self-administer drugs include structural factors (eg, low socioeconomic status and associated lack of social support systems), proximal factors (eg, parental drug use and dependence, as per the DSM-IV, poor quality of parenting, parental depression, and sibling and peer influences), and more distal factors (eg, dru”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [177] Hawkins, 1992, Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention, Psychol Bull source
- cites [178] Sloboda, 2012, Revisiting the concepts of risk and protective factors for understanding the etiology and development of substance use and substance use disorders: implications for prevention, Subst Use Misuse source
Classified as probably not a substantial claim.
InterpretationreasoningThe heuristic framework presents addiction as three stages linked by three functional domains mediated by three major neurobiological circuits (basal ganglia, extended amygdala, prefrontal cortex) and numerous microcircuits of neuroplasticity.
“We elaborate here a heuristic framework based on the behavioural and imaging phenotypes of addiction as three stages linked by three functional domains that are mediated by three major neurobiological circuits (basal ganglia, extended amygdala, and prefrontal cortex) and numerous microcircuits of neuroplasticity.”
Quote in the paperSubstantial claim
The paper relies on this without support.
Neurobiological mechanisms identified in rodent models of reinstatement and craving correspond to the circuits that mediate human addiction.
“Evidence from rodent studies suggests that drug-induced reinstatement is mediated by the circuit that links the prelimbic prefrontal cortex to the ventral striatum94 (for correspondence with humans, see figure 2; tables 1, 2, circuits 12 and possibly 13).”
“In humans, cue-induced craving appears to involve activation of similar circuits, in which cues that are associated with drugs and elements of non-drug addictions produce activation of the prefrontal cortex, including the dorsolateral prefrontal cortex, anterior cingulate gyrus, and medial orbitofrontal cortex.101–105”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Problematic social media use (PSMU) parallels traditional characteristics of substance use disorders, including salience, functional impairment, and tolerance.
“Problematic social media use (PSMU) parallels traditional characteristics of substance use disorders, including salience, functional impairment, and tolerance.”
From Problematic social media use and inhibitory control among post-secondary students (2025) · cites this paper as Koob & Volkow, 2016
The “Relevance to behavioural addictive disorders” section says that internet addiction and other non-drug addictions share features with drug addiction, while the “preoccupation/anticipation” section describes excessive salience of drug-related cues. The paper does not establish that problematic social media use specifically has these parallels, or that its parallels include functional impairment and tolerance. Page numbers were not available in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measuredUpregulation of CRF in the amygdala plays a role in negative emotional states during drug withdrawal.
“Upregulation of CRF in the amygdala in turn plays a role in negative emotional states dur ing drug withdrawal 51 .”
From Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention (2023) · cites this paper as [51]
There is a growing consensus that SUDs, once developed, tend to be chronic disorders, reflecting long-lasting changes in brain function exacerbated by cumulative mental health and social consequences.
“There is a growing consensus that SUDs, once developed, tend to be chronic disorders 161 , reflecting long- lasting changes in brain function 50,51 , that are exacerbated by the cumulative mental health and social consequences that they trigger.”
From Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention (2023) · cites this paper as [51]
Stress plays a powerful role in the initiation, escalation, and relapse to drug abuse via dopaminergic mechanisms.
“such that stress plays a powerful role in the initiation, escalation, and relapse to drug abuse via dopaminergic mechanisms (Koob and Volkow, 2016).”
From The effects of psychosocial stress on dopaminergic function and the acute stress response (2019) · cites this paper as Koob and Volkow, 2016
Addiction is best regarded as a cycle of compulsive substance use subserved by dysregulation in neural circuitry governing motivation and hedonic experience, habit behavior, and executive function.
“addiction is best regarded as a cycle of compulsive substance use subserved by dysregulation in neural circuitry governing motivation and hedonic experience, habit behavior, and executive function [1].”
From Mindfulness-based treatment of addiction: current state of the field and envisioning the next wave of research (2018) · cites this paper as [1]
ANA identifies three neuroscience domains that are grounded in the neurobiology of addiction and overlap with three of the five RDoC domains.
“second, it identifies three neuroscience domains that are not only grounded in the neurobiology of addiction [3], but also overlap with three of the five RDoC domains”
From Addiction Biomarkers: Dimensional Approaches to Understanding Addiction (2018) · cites this paper as [3]
The variants that affect consumption at lower levels may differ substantively from those that affect very high levels of consumption in alcohol dependent individuals, who are also characterized by loss of control over intake.
“We hypothesize that the variants that affect consumption at lower levels may differ substantively from those that affect very high levels of consumption in alcohol dependent individuals, who are also characterized by loss of control over intake33.”
From Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders (2018) · cites this paper as [33]
Cue-induced drug seeking is underpinned by the processes of conditioned reinforcement and incentive salience.
“Cue-induced drug seeking is also underpinned by the processes of conditioned reinforcement [described by Koob and Volkow (51) as a previously neutral stimulus that can reinforce behaviors through its association with a primary reinforcer and thus become a reinforcer in its own right] and incentive salience”
From Craving in Opioid Use Disorder: From Neurobiology to Clinical Practice (2019) · cites this paper as [51]
Modern proponents suggest that downregulation or loss of brain dopamine D2 receptors makes addicts experience less pleasure in their lives than other people, and consequently addicts must take addictive drugs to achieve normal levels of dopamine stimulation and pleasure.
“Modern proponents suggest that downregulation or loss of brain dopamine D2 receptors (one of the two main types of neuronal receptors for dopamine) make addicts experience less pleasure in their lives than other people (Koob and Volkow, 2016; Keramati et al., 2017). Consequently, these theorists argue that addicts must take addictive drugs to achieve normal levels of dopamine stimulation and”
From Evolving Concepts of Emotion and Motivation (2018) · cites this paper as Koob and Volkow, 2016
Opponent-process theory posited negative hedonic states of withdrawal and dysphoria to be the chief force driving addicts to take drugs.
“For example, in drug addiction, the opponent-process theory posited negative hedonic states of withdrawal and dysphoria to be the chief force driving addicts to take drugs (Solomon and Corbit, 1974), a view that still has adherents (Koob and Volkow, 2016; Keramati et al., 2017).”
From Evolving Concepts of Emotion and Motivation (2018) · cites this paper as Koob and Volkow, 2016
The NAc connects directly and indirectly with the dorsal striatum, amygdala, and hippocampus, regions tied to emotion, self-regulation, disinhibition, insight, craving, and habit formation.
“the NAc also maintains direct and indirect involvement with several brain regions, such as the dorsal striatum, amygdala, and hippocampus, areas which are associated with emotions, self-regulation, disinhibition, insight, craving, and habit forming [19].”
The NAc is regarded as the reward circuitry's center and is strongly implicated in substance use and craving.
“The primary subcortical brain target is the nucleus accumbens (NAc) which is considered the center of the reward circuitry and heavily implicated in substance use and craving [18–22].”
Variants near DRD2 were associated with CigDay, SmkCes, and DrnkWk (p=6.5×10−12, 1.1×10−10, and 4.9×10−11, respectively) but not with AgeSmk or SmkInit.
“We found that variants near the widely studied dopamine receptor D2 (DRD2)28 were associated across phenotypes, including CigDay, SmkCes, and DrnkWk (p=6.5×10−12, 1.1×10−10, and 4.9×10−11, respectively) but not with AgeSmk or SmkInit”
From Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use (2019) · cites this paper as [28]
Associations with SmkInit highlighted structures and functions related to long-term potentiation and reward-related learning and memory.
“Associations with SmkInit highlighted structures and functions related to long-term potentiation and reward-related learning and memory, systems that affect reward processing and addiction28,34,35.”
From Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use (2019) · cites this paper as [28]
As a result of drug use and abuse, neuronal circuits involved in reward and fear processing are co-opted to each stage of the addictive cycle and continue to function to maintain addiction.
“As a result of drug use and abuse, different neuronal circuits, such as the circuits involved in reward and fear processing, are co-opted to each stage of the addictive cycle and continue to function to maintain addiction”
From The Insula: A Brain Stimulation Target for the Treatment of Addiction (2019) · cites this paper as Koob and Volkow, 2016
Many of the insula's connectivity constitute areas known to be involved in addiction.
“Many of the insula’s connectivity constitute areas known to be involved in addiction”
From The Insula: A Brain Stimulation Target for the Treatment of Addiction (2019) · cites this paper as Koob and Volkow, 2016
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,841 · see citing works
A neural substrate of prediction and reward
Schultz, W., Dayan, P., & Montague, P. R. (1997) · Science · doi:10.1126/science.275.5306.1593 · Cited by 9,388 · see citing works
Brain development during childhood and adolescence: a longitudinal MRI study
Giedd, J. N., Blumenthal, J., Jeffries, N. O., Castellanos, F. X., Liu, H., Zijdenbos, A., Paus, T., Evans, A. C., & Rapoport, J. L. (1999) · Nature Neuroscience · doi:10.1038/13158 · Cited by 5,552 · see citing works
Hawkins, J. D., Catalano, R. F., & Miller, J. Y. (1992) · Psychological Bulletin · doi:10.1037/0033-2909.112.1.64 · Cited by 5,428 · see citing works
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340 · cited 1× · see citing works
“Modified from Koob and Volkow (2010)9 with permission from Nature Publishing Group.”
MethodSelf-citationLedent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,612 · see citing works
Bardo, M. T., & Hammer, R. P. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90226-e · Cited by 3,229 · see citing works
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953 · see citing works
Self-citationThe somatic marker hypothesis and the possible functions of the prefrontal cortex
Damasio, A. R. (1996) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1996.0125 · Cited by 2,847 · see citing works
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
Goldstein, R. Z., & Volkow, N. D. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3119 · Cited by 2,749 · see citing works
Self-citationPsychiatric Aspects of Impulsivity
Moeller, F. G., Barratt, E. S., Dougherty, D. M., Schmitz, J. M., & Swann, A. C. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1783 · Cited by 2,747 · see citing works
Goldstein, R. Z., & Volkow, N. D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1642 · Cited by 2,667 · see citing works
Self-citationDrug Dependence, a Chronic Medical Illness
McLellan, A. T., Lewis, D. C., O'Brien, C. P., & Kleber, H. D. (2000) · JAMA · doi:10.1001/jama.284.13.1689 · Cited by 2,622 · see citing works
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535 · see citing works
Self-citationCellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070 · see citing works
Self-citationDifferent contributions of the human amygdala and ventromedial prefrontal cortex to decision-making
Bechara, A., Damasio, H., Damasio, A. R., & Lee, G. P. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05473.1999 · Cited by 2,001 · see citing works
Losing control: how and why people fail at self-regulation
(1995) · Choice Reviews Online · doi:10.5860/choice.32-6508 · Cited by 1,924 · see citing works
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722 · see citing works
Niendam, T. A., Laird, A. R., Ray, K. L., Dean, Y. M., Glahn, D. C., & Carter, C. S. (2012) · Cognitive, Affective, & Behavioral Neuroscience · doi:10.3758/s13415-011-0083-5 · Cited by 1,700 · see citing works
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615 · see citing works
Psychopharmacology: The Fourth Generation of Progress
Brophy, J. J. (1995) · JAMA · doi:10.1001/jama.1995.03530220079046 · Cited by 1,582 · see citing works
Jentsch, J. D., & Taylor, J. R. (1999) · Psychopharmacology · doi:10.1007/pl00005483 · Cited by 1,545 · see citing works
Biological studies of post-traumatic stress disorder
Pitman, R. K., Rasmusson, A. M., Koenen, K. C., Shin, L. M., Orr, S. P., Gilbertson, M. W., Milad, M. R., & Liberzon, I. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3339 · Cited by 1,529 · see citing works
Addiction and the brain antireward system
Koob, G. F., & Le Moal, M. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093548 · Cited by 1,457 · see citing works
Self-citationIs there a common molecular pathway for addiction?
Nestler, E. J. (2005) · Nature Neuroscience · doi:10.1038/nn1578 · Cited by 1,388 · see citing works
The glutamate homeostasis hypothesis of addiction
Kalivas, P. W. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2515 · Cited by 1,350 · see citing works
The brain on drugs: from reward to addiction
Volkow, N. D., & Morales, M. (2015) · Cell · doi:10.1016/j.cell.2015.07.046 · Cited by 1,306 · see citing works
Self-citationLateral habenula as a source of negative reward signals in dopamine neurons
Matsumoto, M., & Hikosaka, O. (2007) · Nature · doi:10.1038/nature05860 · Cited by 1,292 · see citing works
Damage to the insula disrupts addiction to cigarette smoking
Naqvi, N. H., Rudrauf, D., Damasio, H., & Bechara, A. (2007) · Science · doi:10.1126/science.1135926 · Cited by 1,245 · see citing works
Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex
Volkow, N. D. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.318 · Cited by 1,240 · see citing works
Self-citationCocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction
Volkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Logan, J., Childress, A.-R., Jayne, M., Ma, Y., & Wong, C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1544-06.2006 · Cited by 1,164 · see citing works
Self-citationMolecular mechanisms of drug addiction
Nestler, E. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.031 · Cited by 1,108 · see citing works
Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons
Ungless, M. A., Whistler, J. L., Malenka, R. C., & Bonci, A. (2001) · Nature · doi:10.1038/35079077 · Cited by 1,106 · see citing works
Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling
Lüscher, C., & Malenka, R. C. (2011) · Neuron · doi:10.1016/j.neuron.2011.01.017 · Cited by 1,105 · see citing works
Molecular mechanisms of opioid receptor-dependent signaling and behavior
Al-Hasani, R., & Bruchas, M. R. (2011) · Anesthesiology · doi:10.1097/aln.0b013e318238bba6 · Cited by 1,067 · see citing works
Johnstone, T., van Reekum, C. M., Urry, H. L., Kalin, N. H., & Davidson, R. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2063-07.2007 · Cited by 1,051 · see citing works
Neuropsychopharmacology: The Fifth Generation of Progress
Sagduyu, K. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1251-a · Cited by 1,023 · see citing works
Imaging dopamine's role in drug abuse and addiction
Volkow, N. D., Fowler, J. S., Wang, G. J., Baler, R., & Telang, F. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.022 · Cited by 988 · see citing works
Self-citationEveritt, B. J., Belin, D., Economidou, D., Pelloux, Y., Dalley, J. W., & Robbins, T. W. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0089 · Cited by 974 · see citing works
Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction
Koob, G. F., & Le Moal, M. (2005) · Nature Neuroscience · doi:10.1038/nn1105-1442 · Cited by 963 · see citing works
Self-citationAddiction: Beyond dopamine reward circuitry
Volkow, N. D., Wang, G.-J., Fowler, J. S., Tomasi, D., & Telang, F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010654108 · Cited by 959 · see citing works
Self-citationThe habenula: from stress evasion to value-based decision-making
Hikosaka, O. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2866 · Cited by 955 · see citing works
Translational control of long-lasting synaptic plasticity and memory
Costa-Mattioli, M., Sossin, W. S., Klann, E., & Sonenberg, N. (2009) · Neuron · doi:10.1016/j.neuron.2008.10.055 · Cited by 944 · see citing works
Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli
Garavan, H., Pankiewicz, J., Bloom, A., Cho, J.-K., Sperry, L., Ross, T. J., Salmeron, B. J., Risinger, R., Kelley, D., & Stein, E. A. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1789 · Cited by 931 · see citing works
Volkow, N. D., Fowler, J. S., Wang, G., Hitzemann, R., Logan, J., Schlyer, D. J., Dewey, S. L., & Wolf, A. P. (1993) · Synapse · doi:10.1002/syn.890140210 · Cited by 924 · see citing works
Self-citationVolkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916 · see citing works
Self-citationThe addicted human brain: insights from imaging studies
Volkow, N. D., Fowler, J. S., & Wang, G.-J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18533 · Cited by 916 · see citing works
Self-citationThe circuitry mediating cocaine-induced reinstatement of drug-seeking behavior
McFarland, K., & Kalivas, P. W. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08655.2001 · Cited by 905 · see citing works
Neurobiology of relapse to heroin and cocaine seeking: a review
Shalev, U., Grimm, J. W., & Shaham, Y. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.1.1 · Cited by 880 · see citing works
Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Hitzemann, R., Chen, A. D., Dewey, S. L., & Pappas, N. (1997) · Nature · doi:10.1038/386830a0 · Cited by 854 · see citing works
Self-citationThe hidden island of addiction: the insula
Naqvi, N. H., & Bechara, A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.09.009 · Cited by 833 · see citing works
Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology
Volkow, N. D., Wang, G.-J., Fowler, J. S., & Telang, F. (2008) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2008.0107 · Cited by 809 · see citing works
Self-citationFormation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving
Conrad, K. L., Tseng, K. Y., Uejima, J. L., Reimers, J. M., Heng, L.-J., Shaham, Y., Marinelli, M., & Wolf, M. E. (2008) · Nature · doi:10.1038/nature06995 · Cited by 790 · see citing works
Regulation of cocaine reward by CREB
Carlezon, W. A., Thome, J., Olson, V. G., Lane-Ladd, S. B., Brodkin, E. S., Hiroi, N., Duman, R. S., Neve, R. L., & Nestler, E. J. (1998) · Science · doi:10.1126/science.282.5397.2272 · Cited by 767 · see citing works
Spear, L. P. (2013) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2012.05.006 · Cited by 744 · see citing works
Wagner, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00367-0 · Cited by 739 · see citing works
Dopamine operates as a subsecond modulator of food seeking
Roitman, M. F., Stuber, G. D., Phillips, P. E. M., Wightman, R. M., & Carelli, R. M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3823-03.2004 · Cited by 718 · see citing works
Losing control: How and why people fail at self-regulation
Horn, D. H. A. V. (1995) · Clinical Psychology Review · doi:10.1016/0272-7358(95)90149-3 · Cited by 717 · see citing works
Psychomotor stimulant addiction: a neural systems perspective
Everitt, B. J., & Wolf, M. E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03312.2002 · Cited by 700 · see citing works
Belin, D., & Everitt, B. J. (2008) · Neuron · doi:10.1016/j.neuron.2007.12.019 · Cited by 697 · see citing works
Piazza, P. V., & Le Moal, M. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.002043 · Cited by 690 · see citing works
McDonald, A. J., Mascagni, F., & Guo, L. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00417-3 · Cited by 689 · see citing works
Images of desire: food-craving activation during fMRI
Pelchat, M. L., Johnson, A., Chan, R., Valdez, J., & Ragland, J. D. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.08.023 · Cited by 667 · see citing works
Habenular α5 nicotinic receptor subunit signalling controls nicotine intake
Fowler, C. D., Lu, Q., Johnson, P. M., Marks, M. J., & Kenny, P. J. (2011) · Nature · doi:10.1038/nature09797 · Cited by 663 · see citing works
Expression of the transcription factor ΔFosB in the brain controls sensitivity to cocaine
Kelz, M. B., Chen, J., Carlezon, W. A., Whisler, K., Gilden, L., Beckmann, A. M., Steffen, C., Zhang, Y.-J., Marotti, L., Self, D. W., et al. (1999) · Nature · doi:10.1038/45790 · Cited by 641 · see citing works
The NPY system in stress, anxiety and depression
Heilig, M. A. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.05.002 · Cited by 617 · see citing works
Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making
Clark, L., Bechara, A., Damasio, H., Aitken, M. R. F., Sahakian, B. J., & Robbins, T. W. (2008) · Brain · doi:10.1093/brain/awn066 · Cited by 613 · see citing works
Molecular and cellular aspects of nicotine abuse
Dani, J. A., & Heinemann, S. (1996) · Neuron · doi:10.1016/s0896-6273(00)80112-9 · Cited by 605 · see citing works
Age at onset of alcohol use and DSM-IV alcohol abuse and dependence: a 12-year follow-up
Grant, B. F., Stinson, F. S., & Harford, T. C. (2001) · Journal of Substance Abuse · doi:10.1016/s0899-3289(01)00096-7 · Cited by 590 · see citing works
Hirvonen, J., Goodwin, R. S., Li, C.-T., Terry, G. E., Zoghbi, S. S., Morse, C., Pike, V. W., Volkow, N. D., Huestis, M. A., & Innis, R. B. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.82 · Cited by 587 · see citing works
Self-citationVolkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Thanos, P. K., Logan, J., Alexoff, D., Ding, Y.-S., Wong, C., Ma, Y., et al. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.06.002 · Cited by 573 · see citing works
Self-citationPich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565 · see citing works
Self-citationBelin, D., Jonkman, S., Dickinson, A., Robbins, T. W., & Everitt, B. J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.09.027 · Cited by 520 · see citing works
Jasinska, A. J., Stein, E. A., Kaiser, J., Naumer, M. J., & Yalachkov, Y. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.10.013 · Cited by 513 · see citing works
Neural systems and cue-induced cocaine craving
Bonson, K. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00371-2 · Cited by 507 · see citing works
Roles for nigrostriatal—not just mesocorticolimbic—dopamine in reward and addiction
Wise, R. A. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.06.004 · Cited by 500 · see citing works
Volkow, N. D., Wang, G.-J., Telang, F., Fowler, J. S., Logan, J., Jayne, M., Ma, Y., Pradhan, K., & Wong, C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3371-07.2007 · Cited by 494 · see citing works
Self-citationRelapse to cocaine-seeking after hippocampal theta burst stimulation
Vorel, S. R., Liu, X., Hayes, R. J., Spector, J. A., & Gardner, E. L. (2001) · Science · doi:10.1126/science.1058043 · Cited by 486 · see citing works
Chudasama, Y., & Robbins, T. W. (2006) · Biological Psychology · doi:10.1016/j.biopsycho.2006.01.005 · Cited by 484 · see citing works
Addiction as a stress surfeit disorder
Koob, G. F., Buck, C. L., Cohen, A., Edwards, S., Park, P. E., Schlosburg, J. E., Schmeichel, B., Vendruscolo, L. F., Wade, C. L., Whitfield, T. W., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.024 · Cited by 483 · see citing works
Self-citationNoradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
Delfs, J. M., Zhu, Y., Druhan, J. P., & Aston-Jones, G. (2000) · Nature · doi:10.1038/35000212 · Cited by 462 · see citing works
Grace, A. A. (2000) · Addiction · doi:10.1046/j.1360-0443.95.8s2.1.x · Cited by 433 · see citing works
Zweifel, L. S., Parker, J. G., Lobb, C. J., Rainwater, A., Wall, V. Z., Fadok, J. P., Darvas, M., Kim, M. J., Mizumori, S. J. Y., Paladini, C. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813415106 · Cited by 426 · see citing works
Janes, A. C., Pizzagalli, D. A., Richardt, S., Frederick, B. D., Chuzi, S., Pachas, G., Culhane, M. A., Holmes, A. J., Fava, M., Evins, A. E., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.12.034 · Cited by 416 · see citing works
Volkow, N. D., Wang, G.-J., Fowler, J. S., Hitzemann, R., Angrist, B., Gatley, S. J., Logan, J., Ding, Y.-S., & Pappas, N. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.1.19 · Cited by 405 · see citing works
Self-citationEnhanced avoidance habits in obsessive-compulsive disorder
Gillan, C. M., Morein-Zamir, S., Urcelay, G. P., Sule, A., Voon, V., Apergis-Schoute, A. M., Fineberg, N. A., Sahakian, B. J., & Robbins, T. W. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.02.002 · Cited by 399 · see citing works
Addictions neuroclinical assessment: a neuroscience-based framework for addictive disorders
Kwako, L. E., Momenan, R., Litten, R. Z., Koob, G. F., & Goldman, D. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.10.024 · Cited by 395 · see citing works
Self-citationInvolvement of the dorsal striatum in cue-controlled cocaine seeking
Vanderschuren, L. J. M. J., Di Ciano, P., & Everitt, B. J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0925-05.2005 · Cited by 393 · see citing works
Pharmacological evidence for a motivational role of κ-opioid systems in ethanol dependence
Walker, B. M., & Koob, G. F. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301438 · Cited by 392 · see citing works
Self-citationCalcium signalling remodelling and disease
Berridge, M. J. (2012) · Biochemical Society Transactions · doi:10.1042/bst20110766 · Cited by 391 · see citing works
Valdez, G. R., Roberts, A. J., Chan, K., Davis, H., Brennan, M., Zorrilla, E. P., & Koob, G. F. (2002) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02448.x · Cited by 387 · see citing works
Self-citationLee, B., London, E. D., Poldrack, R. A., Farahi, J., Nacca, A., Monterosso, J. R., Mumford, J. A., Bokarius, A. V., Dahlbom, M., Mukherjee, J., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3765-09.2009 · Cited by 374 · see citing works
mTOR complexes in neurodevelopmental and neuropsychiatric disorders
Costa-Mattioli, M., & Monteggia, L. M. (2013) · Nature Neuroscience · doi:10.1038/nn.3546 · Cited by 367 · see citing works
Bello, E. P., Mateo, Y., Gelman, D. M., Noaín, D., Shin, J. H., Low, M. J., Alvarez, V. A., Lovinger, D. M., & Rubinstein, M. (2011) · Nature Neuroscience · doi:10.1038/nn.2862 · Cited by 364 · see citing works
Martinez, D., Narendran, R., Foltin, R. W., Slifstein, M., Hwang, D.-R., Broft, A., Huang, Y., Cooper, T. B., Fischman, M. W., Kleber, H. D., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.4.622 · Cited by 351 · see citing works
King, K. M., & Chassin, L. (2007) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2007.68.256 · Cited by 348 · see citing works
Animal models of psychiatric disorders
Koob, G. F., & Zimmer, A. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52002-9.00009-7 · Cited by 337 · see citing works
Self-citationGoudriaan, A. E., De Ruiter, M. B., Van Den Brink, W., Oosterlaan, J., & Veltman, D. J. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00242.x · Cited by 327 · see citing works
Self, D. W., Genova, L. M., Hope, B. T., Barnhart, W. J., Spencer, J. J., & Nestler, E. J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-05-01848.1998 · Cited by 325 · see citing works
Weiss, F., Markou, A., Lorang, M. T., & Koob, G. F. (1992) · Brain Research · doi:10.1016/0006-8993(92)91327-b · Cited by 318 · see citing works
Self-citationStinus, L., Le Moal, M., & Koob, G. F. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90106-e · Cited by 317 · see citing works
Self-citationSalas, R., Sturm, R., Boulter, J., & De Biasi, M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4934-08.2009 · Cited by 310 · see citing works
Gunduz-Cinar, O., MacPherson, K. P., Cinar, R., Gamble-George, J., Sugden, K., Williams, B., Godlewski, G., Ramikie, T. S., Gorka, A. X., Alapafuja, S. O., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.72 · Cited by 307 · see citing works
Volkow, N. D., Wang, G.-J., Ma, Y., Fowler, J. S., Wong, C., Ding, Y.-S., Hitzemann, R., Swanson, J. M., & Kalivas, P. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0433-05.2005 · Cited by 304 · see citing works
Self-citationShaham, Y., Erb, S., Leung, S., Buczek, Y., & Stewart, J. (1998) · Psychopharmacology · doi:10.1007/s002130050608 · Cited by 302 · see citing works
D2R striatopallidal neurons inhibit both locomotor and drug reward processes
Durieux, P. F., Bearzatto, B., Guiducci, S., Buch, T., Waisman, A., Zoli, M., Schiffmann, S. N., & de Kerchove d'Exaerde, A. (2009) · Nature Neuroscience · doi:10.1038/nn.2286 · Cited by 297 · see citing works
FAAH genetic variation enhances fronto-amygdala function in mouse and human
Dincheva, I., Drysdale, A. T., Hartley, C. A., Johnson, D. C., Jing, D., King, E. C., Ra, S., Gray, J. M., Yang, R., DeGruccio, A. M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7395 · Cited by 289 · see citing works
Cognitive control of drug craving inhibits brain reward regions in cocaine abusers
Volkow, N. D., Fowler, J. S., Wang, G.-J., Telang, F., Logan, J., Jayne, M., Ma, Y., Pradhan, K., Wong, C., & Swanson, J. M. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2009.10.088 · Cited by 283 · see citing works
Self-citationAMPA receptor plasticity in the nucleus accumbens after repeated exposure to cocaine
Wolf, M. E., & Ferrario, C. R. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.01.013 · Cited by 271 · see citing works
Vorel, S. R., Ashby, C. R., Paul, M., Liu, X., Hayes, R., Hagan, J. J., Middlemiss, D. N., Stemp, G., & Gardner, E. L. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09595.2002 · Cited by 269 · see citing works
Gambling Disorder and Other Behavioral Addictions: Recognition and Treatment
Yau, Y. H. C., & Potenza, M. N. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000051 · Cited by 267 · see citing works
Neural substrates of abstinence-induced cigarette cravings in chronic smokers
Wang, Z., Faith, M., Patterson, F., Tang, K., Kerrin, K., Wileyto, E. P., Detre, J. A., & Lerman, C. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2966-07.2007 · Cited by 256 · see citing works
Brain Development in Heavy-Drinking Adolescents
Squeglia, L. M., Tapert, S. F., Sullivan, E. V., Jacobus, J., Meloy, M. J., Rohlfing, T., & Pfefferbaum, A. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14101249 · Cited by 245 · see citing works
Relationship between reward-enhancing and stereotypical effects of psychomotor stimulant drugs
ROBBINS, T. W. (1976) · Nature · doi:10.1038/264057a0 · Cited by 241 · see citing works
George, O., Sanders, C., Freiling, J., Grigoryan, E., Vu, S., Allen, C. D., Crawford, E. F., Mandyam, C. D., & Koob, G. F. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116523109 · Cited by 239 · see citing works
Self-citationMitchell, J. M., O’Neil, J. P., Janabi, M., Marks, S. M., Jagust, W. J., & Fields, H. L. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3002902 · Cited by 237 · see citing works
NOW vs LATER brain circuits: implications for obesity and addiction
Volkow, N. D., & Baler, R. D. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.04.002 · Cited by 237 · see citing works
Self-citationHanson, K. L., Medina, K. L., Padula, C. B., Tapert, S. F., & Brown, S. A. (2011) · Journal of Child & Adolescent Substance Abuse · doi:10.1080/1067828x.2011.555272 · Cited by 235 · see citing works
Caine, S. B., Negus, S. S., Mello, N. K., Patel, S., Bristow, L., Kulagowski, J., Vallone, D., Saiardi, A., & Borrelli, E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02977.2002 · Cited by 234 · see citing works
Neural correlates of high and craving during cocaine self-administration using BOLD fMRI
Risinger, R. C., Salmeron, B. J., Ross, T. J., Amen, S. L., Sanfilipo, M., Hoffmann, R. G., Bloom, A. S., Garavan, H., & Stein, E. A. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.03.030 · Cited by 234 · see citing works
Squeglia, L. M., Spadoni, A. D., Infante, M. A., Myers, M. G., & Tapert, S. F. (2009) · Psychology of Addictive Behaviors · doi:10.1037/a0016516 · Cited by 225 · see citing works
Challenges in the manipulation, assessment and interpretation of craving relevant variables
Tiffany, S. T., Carter, B. L., & Singleton, E. G. (2000) · Addiction · doi:10.1046/j.1360-0443.95.8s2.7.x · Cited by 221 · see citing works
Aldehyde dehydrogenase 1a1 mediates a GABA synthesis pathway in midbrain dopaminergic neurons
Kim, J.-I., Ganesan, S., Luo, S. X., Wu, Y.-W., Park, E., Huang, E. J., Chen, L., & Ding, J. B. (2015) · Science · doi:10.1126/science.aac4690 · Cited by 217 · see citing works
CYP2A6 genotype and the metabolism and disposition kinetics of nicotine
BENOWITZ, N., SWAN, G., JACOBIII, P., LESSOVSCHLAGGAR, C., & TYNDALE, R. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.08.011 · Cited by 217 · see citing works
Decreased dopamine activity predicts relapse in methamphetamine abusers
Wang, G. J., Smith, L., Volkow, N. D., Telang, F., Logan, J., Tomasi, D., Wong, C. T., Hoffman, W., Jayne, M., Alia-Klein, N., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.86 · Cited by 214 · see citing works
Self-citationInteraction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use
Blomeyer, D., Treutlein, J., Esser, G., Schmidt, M. H., Schumann, G., & Laucht, M. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.026 · Cited by 211 · see citing works
Bryant, R. A., Felmingham, K. L., Kemp, A. H., Barton, M., Peduto, A. S., Rennie, C., Gordon, E., & Williams, L. M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.021 · Cited by 211 · see citing works
Neuroprotective and Abstinence-Promoting Effects of Acamprosate: Elucidating the Mechanism of Action
De Witte, P., Littleton, J., Parot, P., & Koob, G. (2005) · CNS Drugs · doi:10.2165/00023210-200519060-00004 · Cited by 201 · see citing works
Self-citationShaham, Y., Highfield, D., Delfs, J., Leung, S., & Stewart, J. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00899.x · Cited by 201 · see citing works
Chronic cocaine-regulated epigenomic changes in mouse nucleus accumbens
Feng, J., Wilkinson, M., Liu, X., Purushothaman, I., Ferguson, D., Vialou, V., Maze, I., Shao, N., Kennedy, P., Koo, J., et al. (2014) · Genome Biology · doi:10.1186/gb-2014-15-4-r65 · Cited by 198 · see citing works
Pandey, S. C., Sakharkar, A. J., Tang, L., & Zhang, H. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.03.019 · Cited by 191 · see citing works
Rando, K., Hong, K.-I., Bhagwagar, Z., Li, C.-S. R., Bergquist, K., Guarnaccia, J., & Sinha, R. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10020233 · Cited by 189 · see citing works
Valdez, G. R., Roberts, A., Chan, K., Davis, H., Brennan, M., Zorrilla, E. P., & Koob, G. F. (2002) · PubMed · doi:10.1097/01.alc.0000033120.51856.f0 · Cited by 187 · see citing works
Self-citationTreutlein, J., Kissling, C., Frank, J., Wiemann, S., Dong, L., Depner, M., Saam, C., Lascorz, J., Soyka, M., Preuss, U. W., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001813 · Cited by 186 · see citing works
Lack of Self-Administration of Cocaine in Dopamine D <sub>1</sub> Receptor Knock-Out Mice
Caine, S. B., Thomsen, M., Gabriel, K. I., Berkowitz, J. S., Gold, L. H., Koob, G. F., Tonegawa, S., Zhang, J., & Xu, M. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2284-07.2007 · Cited by 183 · see citing works
Self-citationAge of alcohol-dependence onset: associations with severity of dependence and seeking treatment
Hingson, R. W., Heeren, T., & Winter, M. R. (2006) · Pediatrics · doi:10.1542/peds.2006-0223 · Cited by 182 · see citing works
The burden of complex genetics in brain disorders
Uhl, G. R., & Grow, R. W. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.223 · Cited by 176 · see citing works
Disruption of alcohol-related memories by mTORC1 inhibition prevents relapse
Barak, S., Liu, F., Hamida, S. B., Yowell, Q. V., Neasta, J., Kharazia, V., Janak, P. H., & Ron, D. (2013) · Nature Neuroscience · doi:10.1038/nn.3439 · Cited by 172 · see citing works
Dahchour, A., De Witte, P., Bolo, N., Nédélec, J.-F., Muzet, M., Durbin, P., & Macher, J.-P. (1998) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(98)00016-x · Cited by 165 · see citing works
Brain activity during cocaine craving and gambling urges: an fMRI study
Kober, H., Lacadie, C. M., Wexler, B. E., Malison, R. T., Sinha, R., & Potenza, M. N. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.193 · Cited by 160 · see citing works
Synaptic depression via mGluR1 positive allosteric modulation suppresses cue-induced cocaine craving
Loweth, J. A., Scheyer, A. F., Milovanovic, M., LaCrosse, A. L., Flores-Barrera, E., Werner, C. T., Li, X., Ford, K. A., Le, T., Olive, M. F., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3590 · Cited by 157 · see citing works
Neurobiology of dysregulated motivational systems in drug addiction
Edwards, S., & Koob, G. F. (2010) · Future Neurology · doi:10.2217/fnl.10.14 · Cited by 157 · see citing works
Self-citationDevelopment of pharmacotherapies for drug addiction: a Rosetta stone approach
Koob, G. F., Kenneth Lloyd, G., & Mason, B. J. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2828 · Cited by 154 · see citing works
Self-citationLee, J.-H., Lim, Y., Wiederhold, B. K., & Graham, S. J. (2005) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-005-6377-z · Cited by 153 · see citing works
Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement
Tolu, S., Eddine, R., Marti, F., David, V, Graupner, M., Pons, S., Baudonnat, M., Husson, M., Besson, M., Reperant, C., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.83 · Cited by 151 · see citing works
Editor's Note: The Process Addictions and the New ASAM Definition of Addiction
Smith, D. E. (2012) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2012.662105 · Cited by 147 · see citing works
Role of oxytocin in the neuroadaptation to drugs of abuse
Sarnyai, Z., & Kovács, G. L. (1994) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)90062-0 · Cited by 138 · see citing works
Stimulant-induced dopamine increases are markedly blunted in active cocaine abusers
Volkow, N. D., Tomasi, D., Wang, G.-J., Logan, J., Alexoff, D. L., Jayne, M., Fowler, J. S., Wong, C., Yin, P., & Du, C. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.58 · Cited by 134 · see citing works
Self-citationVTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation
Grieder, T. E., Herman, M. A., Contet, C., Tan, L. A., Vargas-Pérez, H., Cohen, A., Chwalek, M., Maal‐Bared, G., Freiling, J., Schlosburg, J. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3872 · Cited by 132 · see citing works
Self-citationEvidence of CNIH3 involvement in opioid dependence
Nelson, E. C., Agrawal, A., Heath, A. C., Bogdan, R., Sherva, R., Zhang, B., Al-Hasani, R., Bruchas, M. R., Chou, Y.-L., Demers, C. H., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.102 · Cited by 131 · see citing works
Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction
Cunningham, K. A., & Anastasio, N. C. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.06.030 · Cited by 131 · see citing works
Functional implications of glutamatergic projections to the ventral tegmental area
Geisler, S., & Wise, R. A. (2008) · Reviews in the Neurosciences · doi:10.1515/revneuro.2008.19.4-5.227 · Cited by 125 · see citing works
Existing and future drugs for the treatment of the dark side of addiction
Koob, G. F., & Mason, B. J. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103143 · Cited by 121 · see citing works
Self-citationCompulsivity, impulsivity, and the DSM-5 process
Berlin, G. S., & Hollander, E. (2014) · CNS Spectrums · doi:10.1017/s1092852913000722 · Cited by 120 · see citing works
Schlosburg, J. E., Whitfield, T. W., Park, P. E., Crawford, E. F., George, O., Vendruscolo, L. F., & Koob, G. F. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1979-13.2013 · Cited by 119 · see citing works
Self-citationmTOR complex 1: a key player in neuroadaptations induced by drugs of abuse
Neasta, J., Barak, S., Hamida, S. B., & Ron, D. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12725 · Cited by 114 · see citing works
Elucidating the role of genetic factors in smoking behavior and nicotine dependence
Lerman, C., & Berrettini, W. (2003) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.10003 · Cited by 114 · see citing works
Brain Neuropeptide Υ (NPY) in Stress and Alcohol Dependence
Heilig, M. A., & Thorsell, A. (2002) · Reviews in the Neurosciences · doi:10.1515/revneuro.2002.13.1.85 · Cited by 114 · see citing works
Ceccarini, J., Hompes, T., Verhaeghen, A., Casteels, C., Peuskens, H., Bormans, G., Claes, S., & Van Laere, K. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.0849-13.2014 · Cited by 111 · see citing works
Chen, Y., Lu, R., Peng, G., Wang, M., Wang, H., Ko, H., Chang, Y., Lu, J., Li, T., & Yin, S. (1999) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1999.tb04083.x · Cited by 108 · see citing works
Vargas, W. M., Bengston, L., Gilpin, N. W., Whitcomb, B. W., & Richardson, H. N. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3189-13.2014 · Cited by 99 · see citing works
Addiction and arousal: The hypocretin connection
Boutrel, B., & de Lecea, L. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.11.022 · Cited by 99 · see citing works
Drugs, Addiction, and the Brain
(2014) · Elsevier eBooks · doi:10.1016/c2010-0-68399-4 · Cited by 96 · see citing works
Increased NMDA-induced excitability during ethanol withdrawal: a behavioural and histological study
Davidson, M., Shanley, B., & Wilce, P. (1995) · Brain Research · doi:10.1016/0006-8993(94)01440-s · Cited by 94 · see citing works
Sloboda, Z., Glantz, M. D., & Tarter, R. E. (2012) · Substance Use & Misuse · doi:10.3109/10826084.2012.663280 · Cited by 94 · see citing works
Endocannabinoid-mediated synaptic plasticity and addiction-related behavior
Sidhpura, N., & Parsons, L. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.05.034 · Cited by 92 · see citing works
Illicit dopamine transients: reconciling actions of abused drugs
Covey, D. P., Roitman, M. F., & Garris, P. A. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.02.002 · Cited by 90 · see citing works
Herpes simplex virus-mediated gene transfer as a tool for neuropsychiatric research
Carlezon, Jr., Nestler, E. J., & Neve, R. L. (2000) · Critical Reviews™ in Neurobiology · doi:10.1615/critrevneurobiol.v14.i1.30 · Cited by 90 · see citing works
Fotros, A., Casey, K. F., Larcher, K., Verhaeghe, J. A., Cox, S. M., Gravel, P., Reader, A. J., Dagher, A., Benkelfat, C., & Leyton, M. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.77 · Cited by 89 · see citing works
Hancock, D. B., Reginsson, G. W., Gaddis, N. C., Chen, X., Saccone, N. L., Lutz, S. M., Qaiser, B., Sherva, R., Steinberg, S., Zink, F., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.149 · Cited by 85 · see citing works
“The free market” and the Asian crisis
Jones, G. (2000) · Critical Review · doi:10.1080/08913810008443546 · Cited by 85 · see citing works
Experimental Genetic Approaches to Addiction
Laakso, A., Mohn, A. R., Gainetdinov, R. R., & Caron, M. G. (2002) · Neuron · doi:10.1016/s0896-6273(02)00972-8 · Cited by 80 · see citing works
Shi, X., Miller, J. S., Harper, L. J., Poole, R. L., Gould, T. J., & Unterwald, E. M. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3491-8 · Cited by 79 · see citing works
κ opioid receptors in the nucleus accumbens shell mediate escalation of methamphetamine intake
Whitfield, T. W., Schlosburg, J. E., Wee, S., Gould, A., George, O., Grant, Y., Zamora-Martinez, E. R., Edwards, S., Crawford, E., Vendruscolo, L. F., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1978-13.2015 · Cited by 75 · see citing works
Self-citationEconomidou, D., Cippitelli, A., Stopponi, S., Braconi, S., Clementi, S., Ubaldi, M., Martin-Fardon, R., Weiss, F., Massi, M., & Ciccocioppo, R. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2010.01392.x · Cited by 71 · see citing works
Anhedonia and amotivation in psychiatric outpatients with fully remitted stimulant use disorder
Leventhal, A. M., Kahler, C. W., Ray, L. A., Stone, K., Young, D., Chelminski, I., & Zimmerman, M. (2008) · The American Journal on Addictions · doi:10.1080/10550490802019774 · Cited by 63 · see citing works
Cocaine cue-induced dopamine release in the human prefrontal cortex
Milella, M. S., Fotros, A., Gravel, P., Casey, K. F., Larcher, K., Verhaeghe, J. A. J., Cox, S. M. L., Reader, A. J., Dagher, A., Benkelfat, C., et al. (2016) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.150207 · Cited by 56 · see citing works
Verdejo‐Garcia, A., Contreras‐Rodríguez, O., Fonseca, F., Cuenca, A., Soriano‐Mas, C., Rodriguez, J., Pardo‐Lozano, R., Blanco‐Hinojo, L., de Sola Llopis, S., Farré, M., et al. (2014) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00472.x · Cited by 53 · see citing works
Contreras‐Rodríguez, O., Albein‐Urios, N., Perales, J. C., Martínez‐Gonzalez, J. M., Vilar‐López, R., Fernández‐Serrano, M. J., Lozano‐Rojas, O., & Verdejo‐García, A. (2015) · Addiction · doi:10.1111/add.13076 · Cited by 46 · see citing works
Olfson, E., Saccone, N. L., Johnson, E. O., Chen, L.-S., Culverhouse, R., Doheny, K., Foltz, S. M., Fox, L., Gogarten, S. M., Hartz, S., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.105 · Cited by 43 · see citing works
Maldonado, R. J., Girdlestone, D., & Roques, B. P. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90457-v · Cited by 42 · see citing works
Schmidt, H. D., Kimmey, B. A., Arreola, A. C., & Pierce, R. C. (2015) · Addiction Biology · doi:10.1111/adb.12122 · Cited by 38 · see citing works
Nicotine Self-Administration Induces CB1-Dependent LTP in the Bed Nucleus of the Stria Terminalis
Reisiger, A.-R., Kaufling, J., Manzoni, O. J., Cador, M., Georges, F. E., & Caillé, S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3149-13.2014 · Cited by 35 · see citing works
Vashchinkina, E., Panhelainen, A. E., Aitta‐aho, T., & Korpi, E. R. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00256 · Cited by 34 · see citing works
Differential response to IV carfentanil in chronic cocaine users and healthy controls
Minkowski, C. P., Epstein, D., Frost, J. J., & Gorelick, D. A. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00256.x · Cited by 33 · see citing works
Stress psychobiology in the context of addiction medicine
Lemieux, A., & al'Absi, M. (2016) · Progress in Brain Research · doi:10.1016/bs.pbr.2015.08.001 · Cited by 29 · see citing works
What does the habenula tell dopamine neurons?
Kimura, M., Satoh, T., & Matsumoto, N. (2007) · Nature Neuroscience · doi:10.1038/nn0607-677 · Cited by 24 · see citing works
Norman, A. B., Tabet, M. R., Norman, M. K., Fey, B. K., Tsibulsky, V. L., & Millard, R. W. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.183244 · Cited by 10 · see citing works
Slomowitz, M. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11bk07461 · Cited by 3 · see citing works
Koob, G. F. (2012) · Cited by 1 · see citing works
Self-citationS�nchez, M. M., Young, L. J., Plotsky, P. M., & Insel, T. R. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990607)408:3
Flagged first, then by citations
8 of the 199 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Volkow, 2006, Altered pathways: drug abuse and age of onset, Addict Professional, 26, 29
Cited by
Sorted by citations
23andMe Research Team, Liu, M., Psychiatry, H. A.-I., Jiang, Y., Wedow, R., Li, Y., Brazel, D. M., Chen, F., Datta, G., Davila-Velderrain, J., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0307-5 · Cited by 1,896 · see citing works
The oxytocin receptor: from intracellular signaling to behavior
Jurek, B., & Neumann, I. D. (2018) · Physiological Reviews · doi:10.1152/physrev.00031.2017 · Cited by 999 · see citing works
Carvalho, A. F., Heilig, M. A., Perez, A., Probst, C., & Rehm, J. T. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31775-1 · Cited by 678 · see citing works
23andMe Research Team, Walters, R. K., Polimanti, R., Johnson, E. C., McClintick, J. N., Adams, M. J., Adkins, A. E., Aliev, F., Bacanu, S.-A., Batzler, A., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0275-1 · Cited by 632 · see citing works
Fregni, F., El-Hagrassy, M. M., Pacheco‐Barrios, K., Carvalho, S., Leite, J., Simis, M., Brunelin, J., Nakamura-Palacios, E. M., Marangolo, P., Venkatasubramanian, G., et al. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa051 · Cited by 617 · see citing works
Advances in the science and treatment of alcohol use disorder
Witkiewitz, K. A., Litten, R. Z., & Leggio, L. (2019) · Science Advances · doi:10.1126/sciadv.aax4043 · Cited by 599 · see citing works
Prevention and Treatment of Opioid Misuse and Addiction: A Review
Volkow, N. D., Jones, E. B., Einstein, E. B., & Wargo, E. M. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.3126 · Cited by 596 · see citing works
Self-citationZilverstand, A., Huang, A., Nelly Alia-klein, A., & Goldstein, R. Z. (2018) · Neuron · doi:10.1016/j.neuron.2018.03.048 · Cited by 570 · see citing works
Luciana, M. M., Bjork, J. M., Nagel, B. J., Barch, D. M., González, R., Nixon, S. J., & Banich, M. T. (2018) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2018.02.006 · Cited by 523 · see citing works
“Extant models suggest that executive functions, particularly control over the impulse to engage in substance use, are compromised as the process of addiction emerges (Koob and Volkow, 2016).”
The changing opioid crisis: development, challenges and opportunities
Volkow, N. D., & Blanco, C. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0661-4 · Cited by 564 · see citing works
“Animal [52, 53] and human studies consistently indicate that drugs release dopamine (DA) in the nucleus accumbens (NAc), which is fundamental to their rewarding effects.”
BackgroundInfluentialSelf-citationVolkow, N. D., & Blanco, C. (2023) · World psychiatry · doi:10.1002/wps.21073 · Cited by 503 · see citing works
Self-citationThe transition to compulsion in addiction
Lüscher, C., Robbins, T. W., & Everitt, B. J. (2020) · Nature reviews. Neuroscience · doi:10.1038/s41583-020-0289-z · Cited by 475 · see citing works
Circuits and functions of the lateral habenula in health and in disease
Hu, H., Cui, Y., & Yang, Y. (2020) · Nature reviews. Neuroscience · doi:10.1038/s41583-020-0292-4 · Cited by 471 · see citing works
Alcohol and the Brain: Neuronal Molecular Targets, Synapses, and Circuits
Abrahao, K. P., Salinas, A. G., & Lovinger, D. M. (2017) · Neuron · doi:10.1016/j.neuron.2017.10.032 · Cited by 438 · see citing works
Mindfulness Meditation and Psychopathology
Wielgosz, J., Goldberg, S. B., Kral, T. R. A., Dunne, J. D., & Davidson, R. J. (2019) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-021815-093423 · Cited by 435 · see citing works
“Given strong neuroscientific models of substance use (Koob & Volkow 2016), the use of mechanistic clinical trial designs combining neural and behavioral measures will be especially valuable in this area.”
BackgroundSex differences in stress-related alcohol use
Peltier, M. R., Verplaetse, T. L., Mineur, Y. S., Petrakis, I. L., Cosgrove, K., Picciotto, M. R., & McKee, S. A. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2019.100149 · Cited by 416 · see citing works
Social brain, social dysfunction and social withdrawal
Porcelli, S., van der Wee, N. J. A., van der Werff, S. J., Aghajani, M., Glennon, J. C., van Heukelum, S., Mogavero, F., Lobo, A., Olivera, F. J. N., Lobo, E., et al. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.012 · Cited by 397 · see citing works
Alcohol use disorder relapse factors: A systematic review.
Sliedrecht, W., de Waart, R., Witkiewitz, K., & Roozen, H. G. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.05.038 · Cited by 358 · see citing works
Brain default-mode network dysfunction in addiction
Zhang, R., & Volkow, N. D. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2019.06.036 · Cited by 365 · see citing works
Self-citationOpioid receptors: drivers to addiction?
Darcq, E., & Kieffer, B. L. (2018) · Nature reviews. Neuroscience · doi:10.1038/s41583-018-0028-x · Cited by 354 · see citing works
One Is Not Enough: Understanding and Modeling Polysubstance Use
Crummy, E. A., O’Neal, T. J., Baskin, B. M., & Ferguson, S. M. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00569 · Cited by 351 · see citing works
Hot and cold executive functions in the brain: A prefrontal-cingular network
Salehinejad, M. A., Ghanavati, E., Rashid, M. H. A., & Nitsche, M. A. (2021) · Brain and Neuroscience Advances · doi:10.1177/23982128211007769 · Cited by 344 · see citing works
“In the first two stages (binge/intoxication and withdrawal/negative affect), a deficient reward system is central (Koob and Volkow, 2016), which is related to a deficient hot cognition, and in the preoccupation/anticipation stage, where craving behaviour dominates, a deficient executive control system is relevantly in…”
InfluentialThe mouse cortico–basal ganglia–thalamic network
Foster, N. N., Barry, J., Korobkova, L., Garcia, L., Gao, L., Becerra, M., Sherafat, Y., Peng, B., Li, X., Choi, J.-H., et al. (2021) · Nature · doi:10.1038/s41586-021-03993-3 · Cited by 307 · see citing works
Addiction and Stress: An Allostatic View
Koob, G. F., & Schulkin, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.008 · Cited by 315 · see citing works
Self-citationAmaro, H. D. L. A., Sánchez, M., Bautista, T. G., & Cox, R. J. A. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108518 · Cited by 334 · see citing works
Ekhtiari, H., Tavakoli, H., Addolorato, G., Baeken, C., Bonci, A., Campanella, S., Castelo-Branco, L. E. C., Challet‐Bouju, G., Clark, V. P., Claus, E. D., et al. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.06.007 · Cited by 305 · see citing works
“reward seeking), abstinence induced withdrawal (negative affect) and drug craving brain circuits and networks (For review, see; Koob and Volkow, 2016; Spronk et al., 2013; Steele et al., 2018a).”
BackgroundGarland, E. L., & Howard, M. O. (2018) · Addiction Science & Clinical Practice · doi:10.1186/s13722-018-0115-3 · Cited by 300 · see citing works
“This large body of research suggests that addiction is best regarded as a cycle of compulsive substance use subserved by dysregulation in neural circuitry governing motivation and hedonic experience, habit behavior, and executive function [1].”
BackgroundEvolving Concepts of Emotion and Motivation
Berridge, K. C. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.01647 · Cited by 273 · see citing works
The future of rodent models in depression research
Gururajan, A., Reif, A., Cryan, J. F., & Slattery, D. A. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0221-6 · Cited by 269 · see citing works
Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework
Koob, G. F., & Colrain, I. M. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0446-0 · Cited by 280 · see citing works
Self-citationLinking RDoC and HiTOP: A new interface for advancing psychiatric nosology and neuroscience
Michelini, G., Palumbo, I. M., DeYoung, C. G., Latzman, R. D., & Kotov, R. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.102025 · Cited by 285 · see citing works
The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders
Klausen, M. K., Thomsen, M., Wortwein, G., & Fink‐Jensen, A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15677 · Cited by 259 · see citing works
“A large literature suggests that activation of stress systems contributes to the addictive effects of various drugs of abuse, in the withdrawal and ‘negative affect’ stages of addiction (Koob, 2008; Koob & Volkow, 2016).”
BackgroundCannabis and mental illness: a review
Lowe, D. J. E., Sasiadek, J., Coles, A. S., & George, T. P. (2018) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-018-0970-7 · Cited by 260 · see citing works
“These neurobiological and psychological changes mark the initial process in drug use and addiction, with mesocorticolimbic dopamine transmission playing a key role alongside the other neurotransmitter activations in regions including the ventral tegmental area, nucleus accumbens, and frontal cortex [86].”
Cannabis Addiction and the Brain: a Review
Zehra, A., Burns, J. A., Liu, C. K., Manza, P., Wiers, C. E., Volkow, N. D., & Wang, G. (2018) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-018-9782-9 · Cited by 258 · see citing works
Self-citationThe Mesolimbic Dopamine System in Chronic Pain and Associated Affective Comorbidities
Serafini, R. A., Pryce, K. D., & Zachariou, V. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.10.018 · Cited by 237 · see citing works
Stress-induced plasticity and functioning of ventral tegmental dopamine neurons
Douma, E. H., & de Kloet, E. R. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.10.015 · Cited by 226 · see citing works
Chapter 1. Neurocircuitry of Addiction
Koob, G. F., & Volkow, N. D. (2021) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615373970.kb01 · Cited by 236 · see citing works
Self-citationPergolizzi, J. V., Raffa, R. B., & Rosenblatt, M. (2020) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13114 · Cited by 234 · see citing works
Neuroimmune signaling in alcohol use disorder
Erickson, E. K., Grantham, E. K., Warden, A. S., & Harris, R. A. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.12.007 · Cited by 224 · see citing works
Brain lesions disrupting addiction map to a common human brain circuit
Joutsa, J., Moussawi, K., Siddiqi, S., Abdolahi, A., Drew, W., Cohen, A. L., Ross, T. J., Deshpande, H. U., Wang, H. Z., Bruss, J., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-01834-y · Cited by 221 · see citing works
Self-citationBolton, J. L., Molet, J., Regev, L., Chen, Y., Rismanchi, N., Haddad, E., Yang, D. Z., Obenaus, A., & Baram, T. Z. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.08.023 · Cited by 215 · see citing works
Sex Differences in the Neurobiology of Alcohol Use Disorder
Flores‐Bonilla, A. (2020) · Alcohol research · doi:10.35946/arcr.v40.2.04 · Cited by 201 · see citing works
Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review
Siefried, K. J., Acheson, L. S., Lintzeris, N., & Ezard, N. (2020) · CNS Drugs · doi:10.1007/s40263-020-00711-x · Cited by 194 · see citing works
A Gender Perspective of Addictive Disorders
Fonseca, F., Robles-Martínez, M., Tirado-Muñoz, J., Alías-Ferri, M., Mestre-Pintó, J. I., Coratu, A. M., & Torrens, M. (2021) · Current Addiction Reports · doi:10.1007/s40429-021-00357-9 · Cited by 192 · see citing works
Cocaine Self-administration Alters Transcriptome-wide Responses in the Brain’s Reward Circuitry
Walker, D. M., Cates, H. M., Loh, Y. E., Purushothaman, I., Ramakrishnan, A., Cahill, K. M., Lardner, C. K., Godino, A., Kronman, H. G., Rabkin, J., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.04.009 · Cited by 177 · see citing works
Dresp, B., & Hutt, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19116910 · Cited by 182 · see citing works
“Dopamine thus governs the reinforcement of normal as well as pathological response habits by modulating synaptic plasticity [75], a central factor in neuroadaptation theories of addiction [76].”
BackgroundSong, S., Zilverstand, A., Gui, W., Li, H., & Zhou, X. (2018) · Brain stimulation · doi:10.1016/j.brs.2018.12.975 · Cited by 172 · see citing works
Neurobiology of cue-reactivity, craving, and inhibitory control in non-substance addictive behaviors
Antons, S., Brand, M., & Potenza, M. N. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116952 · Cited by 165 · see citing works
Simola, N., & Granon, S. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.008 · Cited by 156 · see citing works
Genetic studies of alcohol dependence in the context of the addiction cycle
Reilly, M. T., Noronha, A., Goldman, D. A., & Koob, G. F. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.017 · Cited by 155 · see citing works
“(Koob and Volkow, 2016).”
Self-citationDopamine and addiction: what have we learned from 40 years of research
Solinas, M., Belujon, P., Fernagut, P., Jaber, M., & Thiriet, N. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1957-2 · Cited by 155 · see citing works
Synaptic targets: chronic alcohol actions
Roberto, M., & Varodayan, F. P. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.013 · Cited by 149 · see citing works
“Dependence is generally described by the symptomology elicited during and following EtOH withdrawal (Heilig et al., 2010; Koob, 2003; Koob and Volkow, 2010, 2016; Tsai and Coyle, 1998), including anxiety, dysphoria, increased seizure susceptibility, hyperalgesia and sleep disturbances (Enoch, 2008;…”
Towers, E. B., Williams, I. L., Qillawala, E. I., Rissman, E. F., & Lynch, W. J. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000361 · Cited by 149 · see citing works
Insights from Preclinical Choice Models on Treating Drug Addiction
Banks, M. L., & Negus, S. S. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.11.002 · Cited by 144 · see citing works
“Second, emerging evidence has implicated the dynorphin/kappa opioid receptor (KOR) as one potential neurobiological modulator of drug reinforcement and, as a result, KORs may have therapeutic potential as a substance-use disorder pharmacotherapy target (reviewed in [67,68]).”
BackgroundNew developments in the biology of fibroblast growth factors
Ornitz, D. M., & Itoh, N. (2022) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1549 · Cited by 143 · see citing works
A systematic review and meta-analysis of neuromodulation therapies for substance use disorders
Mehta, D. D., Praecht, A., Ward, H. B., Sanches, M., Sorkhou, M., Tang, V. M., Steele, V. R., Hanlon, C. A., & George, T. P. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01776-0 · Cited by 157 · see citing works
“Reinforcing effects of substances are primarily mediated by mesocorticolimbic systems, which include midbrain dopamine (DA) projections to prefrontal cortex (PFC) and ventral striatum [nucleus accumbens (NAc)] [10, 11].”
BackgroundEpigenetic basis of the dark side of alcohol addiction
Pandey, S. C., Kyzar, E. J., & Zhang, H. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.02.002 · Cited by 143 · see citing works
“The primary goal of this review is to develop a model that integrates the observed epigenetic and neuronal adaptations seen in alcohol addiction with the heuristic framework of addiction and allostasis developed previously (Koob, 2003; Koob and Volkow, 2016).”
InfluentialCraving in Opioid Use Disorder: From Neurobiology to Clinical Practice
Kakko, J., Alho, H., Baldacchino, A., Molina, R., Nava, F. A., & Shaya, G. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00592 · Cited by 140 · see citing works
Individual differences in the neuropsychopathology of addiction
George, O., & Koob, G. F. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.3/gkoob · Cited by 140 · see citing works
Self-citationFood Addiction: Implications for the Diagnosis and Treatment of Overeating
Adams, R. C., Sedgmond, J., Maizey, L., Chambers, C., & Lawrence, N. (2019) · Nutrients · doi:10.3390/nu11092086 · Cited by 143 · see citing works
Human Genetics of Addiction: New Insights and Future Directions
Hancock, D. B., Markunas, C. A., Bierut, L. J., & Johnson, E. O. (2018) · Current Psychiatry Reports · doi:10.1007/s11920-018-0873-3 · Cited by 142 · see citing works
Hamilton, P. J., & Nestler, E. J. (2019) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.05.005 · Cited by 137 · see citing works
Alcohol Use Disorders in ICD‐11: Past, Present, and Future
Saunders, J. B., Degenhardt, L., Reed, G. M., & Poznyak, V. (2019) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.14128 · Cited by 135 · see citing works
21st century neurobehavioral theories of decision making in addiction: Review and evaluation
Bickel, W. K., Mellis, A. M., Snider, S. E., Athamneh, L. N., Stein, J. S., & Pope, D. A. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.09.009 · Cited by 134 · see citing works
“Based largely on imaging evidence, Volkow and Baler (see also Koob and Volkow, 2016; Volkow and Baler, 2014; Volkow et al., 2011, 2012, 2016) recently posited a DA-related theory that, in its earliest form, was based on the premise that the capacity to inhibit drug use during craving and withdrawal…”
The Insula: A Brain Stimulation Target for the Treatment of Addiction
Ibrahim, C., Rubin-Kahana, D. S., Pushparaj, A., Musiol, M., Blumberger, D. M., Daskalakis, Z. J., Zangen, A., & Le Foll, B. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00720 · Cited by 133 · see citing works
Hedonic Eating and the “Delicious Circle”: From Lipid-Derived Mediators to Brain Dopamine and Back
Coccurello, R., & Maccarrone, M. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00271 · Cited by 133 · see citing works
“Stress increases not only the impact of incentive salience of drug of abuse (Koob and Volkow, 2017), but also the rewarding value of palatable food (Adam and Epel, 2007).”
BackgroundOpioid Use Disorders: Perioperative Management of a Special Population
Ward, E. N., Quaye, A., & Wilens, T. E. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000003477 · Cited by 133 · see citing works
Sugar Addiction: From Evolution to Revolution
Wiss, D. A., Avena, N. M., & Rada, P. V. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00545 · Cited by 138 · see citing works
Alizadehgoradel, J., Nejati, V., Movahed, F. S., Imani, S., Taherifard, M., Mosayebi-Samani, M., Vicario, C. M., Nitsche, M. A., & Salehinejad, M. A. (2020) · Brain stimulation · doi:10.1016/j.brs.2019.12.028 · Cited by 129 · see citing works
“Deficits in EFs in individuals with SUD are reflected by decreases in frontal cortex activity that interfere with decision-making, selfregulation, inhibitory control, and WM performance, which contribute to compulsive drug use and loss of control in addiction [3,54].”
BackgroundInfluentialFood and drug addictions: Similarities and differences
Rogers, P. J. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.01.001 · Cited by 130 · see citing works
“In particular, druginduced neural changes in cortical and basal ganglia structures, involving for example dopaminergic, GABAergic and opioid peptidergic neurocircuitry, are thought to be critical in the development of drug addiction (Everitt and Robbins, 2005; Koob and Volkow, 2016).”
BackgroundInfluentialPathological overeating: emerging evidence for a compulsivity construct
Moore, C. F., Sabino, V., Koob, G. F., & Cottone, P. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.269 · Cited by 126 · see citing works
“Drug addiction has been characterized as being composed of three stages: binge/ intoxication, withdrawal/negative effect, and preoccupationanticipation; these three stages, which provide a powerful impetus for the compulsive drug-seeking behavior, reflect incentive salience/pathological habits, reward deficits/stress…”
InfluentialSelf-citationKokane, S. S., & Perrotti, L. I. (2020) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.00074 · Cited by 123 · see citing works
“…between dorsal and ventral striatal circuits (Becker, 2016); quantitative, population, and mechanistic sex differences in addiction (Becker and Koob, 2016); basic biological differences between males and females that influence addictive behaviors (Becker et al., 2017); sex differences in…”
BackgroundLorenzetti, V., Chye, Y., Silva, P., Solowij, N., & Roberts, C. A. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-00979-1 · Cited by 125 · see citing works
Farokhnia, M., Grodin, E. N., Lee, M. R., Oot, E. N., Blackburn, A. N., Stangl, B. L., Schwandt, M. L., Farinelli, L. A., Momenan, R., Ramchandani, V. A., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.226 · Cited by 120 · see citing works
Stress and substance use disorders: risk, relapse, and treatment outcomes
Sinha, R. (2024) · Journal of Clinical Investigation · doi:10.1172/jci172883 · Cited by 145 · see citing works
A competitive model for striatal action selection
Bariselli, S., Fobbs, W. C., Creed, M. C., & Kravitz, A. V. (2018) · Brain Research · doi:10.1016/j.brainres.2018.10.009 · Cited by 113 · see citing works
Optogenetic self-stimulation in the nucleus accumbens: D1 reward versus D2 ambivalence
Cole, S. L., Robinson, M. J. F., & Berridge, K. C. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207694 · Cited by 108 · see citing works
Xiao, C., Zhou, C., Jiang, J., & Cui, Y. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-019-0299-4 · Cited by 120 · see citing works
Nicosia, N., Giovenzana, M., Misztak, P., Mingardi, J., & Musazzi, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126521 · Cited by 135 · see citing works
Mahoney, J. J., Hanlon, C. A., Marshalek, P. J., Rezai, A. R., & Krinke, L. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117149 · Cited by 121 · see citing works
Abuse potential and toxicity of the synthetic cathinones (i.e., “Bath salts”)
Riley, A. L., Nelson, K. H., To, P., López‐Arnau, R., Xu, P., Wang, D., Wang, Y., Shen, H., Kuhn, D. M., Angoa‐Pérez, M., et al. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.07.015 · Cited by 117 · see citing works
“, 2014), and like amphetamine they increase levels of brain monoamines such as norepinephrine (NE), serotonin (5-HT) and dopamine (DA), thought to be involved in the stimulant and rewarding effects of a number of drugs of abuse (Baumann et al., 2013a; Koob and Volkow, 2016; López-Arnau et al., 2012; Watterson and Oliv…”
BackgroundThe Incentive-Sensitization Theory of Addiction 30 Years On
Robinson, T. E., & Berridge, K. C. (2024) · Annual Review of Psychology · doi:10.1146/annurev-psych-011624-024031 · Cited by 137 · see citing works
“…a result, persons with addiction no longer experience the same degree of euphoria from a drug as they did when they first started using it,” and “the down-regulation of dopamine signaling…dulls the reward circuits’ sensitivity to pleasure” (Volkow et al. 2016, p. 366; but see Compton et al. 2022).”
InfluentialThe effects of psychosocial stress on dopaminergic function and the acute stress response
Bloomfield, M. A., McCutcheon, R. A., Kempton, M., Freeman, T. P., & Howes, O. (2019) · eLife · doi:10.7554/elife.46797 · Cited by 112 · see citing works
Hatoum, A. S., Johnson, E. C., Colbert, S. M. C., Polimanti, R. A., Zhou, H., Walters, R. K., Gelernter, J. E., Edenberg, H. J., Bogdan, R., & Arpana Agrawal, A. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-01209-w · Cited by 113 · see citing works
“Following repeated drug-reward and drug-homeostasis pairings, cognitive preoccupation with the drug in expectation of reward/ relief emerges in the context of impaired executive functioning [20].”
BackgroundCentral and Peripheral Biomarkers of Stress Response for Addiction Risk and Relapse Vulnerability
Milivojevic, V., & Sinha, R. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.12.010 · Cited by 118 · see citing works
“These include psychological models that view drug use and abuse as a coping strategy to deal with stress, reduce tension, self-medicate, or decrease withdrawal-related distress, as well as neurobiological models that propose incentive sensitization and stress allostasis concepts to explain how neuroadaptations in stre…”
BackgroundMoeller, S. J., & Paulus, M. P. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.03.003 · Cited by 118 · see citing works
“These paradigms could include the induction of stress, which is highly relevant to opponent process/anti-reward theories of addiction (Koob and Volkow, 2016) and indeed has been examined in the context of imaging drug relapse in one study (Seo et al.”
Role of the endocannabinoid system in drug addiction
Manzanares, J., Cabañero, D., Puente, N., García‐Gutiérrez, M. S., Grandes, P., & Maldonado, R. J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.09.013 · Cited by 116 · see citing works
The role of stress in drug addiction. An integrative review
Ruisoto, P., & Contador, I. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.01.022 · Cited by 119 · see citing works
The Role of the Central Amygdala in Alcohol Dependence
Roberto, M., Kirson, D., & Khom, S. (2021) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a039339 · Cited by 112 · see citing works
Tette, F.-M., Kwofie, S. K., & Wilson, M. D. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44040096 · Cited by 114 · see citing works
Domingo-Rodriguez, L., Ruiz de Azua, I., Dominguez, E., Senabre, E., Serra, I., Kummer, S., Navandar, M., Baddenhausen, S., Hofmann, C., Andero, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14458-y · Cited by 109 · see citing works
Alcohol Craving Predicts Relapse After Residential Addiction Treatment
Stohs, M. E., Schneekloth, T. D., Geske, J. R., Biernacka, J. M., & Karpyak, V. M. (2018) · Alcohol and Alcoholism · doi:10.1093/alcalc/agy093 · Cited by 106 · see citing works
Modelling depression in animals: at the interface of reward and stress pathways
Slattery, D. A., & Cryan, J. F. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4552-6 · Cited by 110 · see citing works
Montag, C., Zhao, Z.-Y., Sindermann, C., Xu, L., Fu, M.-N., Li, J., Zheng, X.-X., Li, K.-S., Kendrick, K., Dai, J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19904-y · Cited by 98 · see citing works
Zeng, J., Yu, S., Cao, H., Su, Y., Dong, Z., & Yang, X. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.031 · Cited by 109 · see citing works
Zheng, H., Hu, Y.-B., Wang, Z.-L., Wang, M., Du, X.-X., & Dong, G. (2019) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109656 · Cited by 100 · see citing works
Addiction Biomarkers: Dimensional Approaches to Understanding Addiction
Kwako, L. E., Bickel, W. K., & Goldman, D. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.12.007 · Cited by 103 · see citing works
“grounded in the neurobiology of addiction [3], but also overlap with three of the five RDoC domains; third, it integrates measures for an understanding of the overall functioning of a domain; and fourth, it is a research approach for assessment of addiction, not capable, or intended to diagnose DSM-based alcohol/subst…”
BackgroundOverlapping Neural Endophenotypes in Addiction and Obesity
Michaud, A., Vainik, U., García‐García, I., & Dagher, A. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00127 · Cited by 103 · see citing works
“org June 2017 | Volume 8 | Article 127 heightened negative emotionality (129, 130).”
BackgroundResultPriddy, S. E., Howard, M. O., Hanley, A. W., Riquino, M. R., Friberg-Felsted, K., & Garland, E. L. (2018) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s145201 · Cited by 101 · see citing works
“44 This cycle creates allostatic neuroadaptations in the brain’s reward and stress systems, which ultimately lead to decreased responsiveness to natural rewards, increased sensitivity to stress, and automatic, conditioned responses to drug cues that drive substance use behavior.”
BackgroundAlcohol use disorders and ADHD.
Luderer, M., Ramos Quiroga, J. A., Faraone, S. V., Zhang-James, Y., & Reif, A. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.010 · Cited by 102 · see citing works
- Authors
- Koob, G. F., & Volkow, N. D.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Koob, George F
- Venue
- The Lancet Psychiatry
- Publisher
- Elsevier BV
- Published
- 2016-08
- Volume
- 3
- Issue
- 8
- Pages
- 760-773
- ISSN
- 2215-0366 (ISSN-L)
- PMC
- PMC6135092
- OpenAlex
- W2491859250
- Semantic Scholar
- 2394bfa642d20cb2f5bcc54ba45b41651539e825
- Cited by
- 3,698
- References
- 199
- Citations by year
- 2026: 507 · 2025: 488 · 2024: 437 · 2023: 423 · 2022: 393 · 2021: 441 · 2020: 359 · 2019: 262 · 2018: 235 · 2017: 136 · 2016: 15
- FWCI
- 23.74
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- The Lancet Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (Z99‐AA999999)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- drug addiction, neurocircuitry, incentive salience, basal ganglia, dopamine, opioid peptides, extended amygdala, corticotropin-releasing factor, dynorphin, stress response, withdrawal, craving, executive function, prefrontal cortex, insula, glutamate, addiction relapse, addiction vulnerability, transcription factors
- MeSH terms
- Brain, Humans, Neural Pathways, Neurobiology, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read under definition version 3 (extract-v3) on 2026-09-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review